<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-11-01" modified="2020-06-17" version="266">
<accession>P04150</accession>
<accession>A0ZXF9</accession>
<accession>B0LPG8</accession>
<accession>D3DQF4</accession>
<accession>F5ATB7</accession>
<accession>P04151</accession>
<accession>Q53EP5</accession>
<accession>Q6N0A4</accession>
<name>GCR_HUMAN</name>
<protein>
<recommendedName>
<fullName>Glucocorticoid receptor</fullName>
<shortName>GR</shortName>
</recommendedName>
<alternativeName>
<fullName>Nuclear receptor subfamily 3 group C member 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NR3C1</name>
<name type="synonym">GRL</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1985" name="Nature" volume="318" first="635" last="641">
<title>Primary structure and expression of a functional human glucocorticoid receptor cDNA.</title>
<authorList>
<person name="Hollenberg S.M."/>
<person name="Weinberger C."/>
<person name="Ong E.S."/>
<person name="Cerelli G."/>
<person name="Oro A."/>
<person name="Lebo R."/>
<person name="Thompson E.B."/>
<person name="Rosenfeld M.G."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="2867473"/>
<dbReference type="DOI" id="10.1038/318635a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA)</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="7182" last="7188">
<title>The genomic structure of the human glucocorticoid receptor.</title>
<authorList>
<person name="Encio I.J."/>
<person name="Detera-Wadleigh S.D."/>
</authorList>
<dbReference type="PubMed" id="1707881"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS ALPHA AND BETA)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2011" name="Nucleic Acids Res." volume="39" first="44" last="58">
<title>Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing.</title>
<authorList>
<person name="Wang W."/>
<person name="Shen P."/>
<person name="Thiyagarajan S."/>
<person name="Lin S."/>
<person name="Palm C."/>
<person name="Horvath R."/>
<person name="Klopstock T."/>
<person name="Cutler D."/>
<person name="Pique L."/>
<person name="Schrijver I."/>
<person name="Davis R.W."/>
<person name="Mindrinos M."/>
<person name="Speed T.P."/>
<person name="Scharfe C."/>
</authorList>
<dbReference type="PubMed" id="20843780"/>
<dbReference type="DOI" id="10.1093/nar/gkq750"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="Ann. N. Y. Acad. Sci." volume="1095" first="334" last="341">
<title>A new transcript splice variant of the human glucocorticoid receptor: identification and tissue distribution of hGR Delta 313-338, an alternative exon 2 transactivation domain isoform.</title>
<authorList>
<person name="Turner J.D."/>
<person name="Schote A.B."/>
<person name="Keipes M."/>
<person name="Muller C.P."/>
</authorList>
<dbReference type="PubMed" id="17404046"/>
<dbReference type="DOI" id="10.1196/annals.1397.037"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 10)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2011" name="Shock" volume="36" first="339" last="344">
<title>Novel hyperactive glucocorticoid receptor isoform identified within a human population.</title>
<authorList>
<person name="Tung K."/>
<person name="Baker A.C."/>
<person name="Amini A."/>
<person name="Green T.L."/>
<person name="Chew V.W."/>
<person name="Lim D."/>
<person name="Nguyen S.T."/>
<person name="Yee K.S."/>
<person name="Cho K."/>
<person name="Greenhalgh D.G."/>
</authorList>
<dbReference type="PubMed" id="21701417"/>
<dbReference type="DOI" id="10.1097/shk.0b013e318228eca7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA)</scope>
<scope>VARIANTS ASP-72; ALA-321 AND SER-766</scope>
<scope>CHARACTERIZATION OF VARIANTS ASP-72; ALA-321 AND SER-766</scope>
</reference>
<reference key="6">
<citation type="submission" date="1993-09" db="EMBL/GenBank/DDBJ databases">
<title>Alternative splicing within the DNA binding domain creates a novel isoform of the human glucocorticoid receptor.</title>
<authorList>
<person name="Munroe D.G."/>
<person name="Pang J."/>
<person name="Taylor G.R."/>
<person name="Lau C."/>
<person name="Plante R.K."/>
<person name="Zhou L."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-2)</scope>
<source>
<tissue>Osteosarcoma</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA)</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA)</scope>
<source>
<tissue>Uterine endothelium</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2003-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LYS-23 AND VAL-65</scope>
</reference>
<reference key="10">
<citation type="submission" date="2007-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="8711" last="8719">
<title>Purification of a human glucocorticoid receptor gene promoter-binding protein. Production of polyclonal antibodies against the purified factor.</title>
<authorList>
<person name="Leclerc S."/>
<person name="Xie B.X."/>
<person name="Roy R."/>
<person name="Govindan M.V."/>
</authorList>
<dbReference type="PubMed" id="2026589"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-394</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1991" name="J. Steroid Biochem. Mol. Biol." volume="40" first="317" last="323">
<title>Human glucocorticoid receptor gene promotor-homologous down regulation.</title>
<authorList>
<person name="Govindan M.V."/>
<person name="Pothier F."/>
<person name="Leclerc S."/>
<person name="Palaniswami R."/>
<person name="Xie B."/>
</authorList>
<dbReference type="PubMed" id="1958537"/>
<dbReference type="DOI" id="10.1016/0960-0760(91)90197-d"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-394</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1985" name="Nature" volume="318" first="670" last="672">
<title>Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product.</title>
<authorList>
<person name="Weinberger C."/>
<person name="Hollenberg S.M."/>
<person name="Rosenfeld M.G."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="3841189"/>
<dbReference type="DOI" id="10.1038/318670a0"/>
</citation>
<scope>DOMAINS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1993" name="Cancer Res." volume="53" first="3877" last="3879">
<title>Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells.</title>
<authorList>
<person name="Moalli P.A."/>
<person name="Pillay S."/>
<person name="Krett N.L."/>
<person name="Rosen S.T."/>
</authorList>
<dbReference type="PubMed" id="8358712"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORMS GR-P; GR-A ALPHA AND GR-A BETA)</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1995" name="J. Clin. Invest." volume="95" first="2435" last="2441">
<title>Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans.</title>
<authorList>
<person name="Bamberger C.M."/>
<person name="Bamberger A.M."/>
<person name="de Castro M."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="7769088"/>
<dbReference type="DOI" id="10.1172/jci117943"/>
</citation>
<scope>FUNCTION (ISOFORM BETA)</scope>
<scope>TISSUE SPECIFICITY (ISOFORM BETA)</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="9550" last="9559">
<title>The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function.</title>
<authorList>
<person name="Oakley R.H."/>
<person name="Sar M."/>
<person name="Cidlowski J.A."/>
</authorList>
<dbReference type="PubMed" id="8621628"/>
<dbReference type="DOI" id="10.1074/jbc.271.16.9550"/>
</citation>
<scope>FUNCTION (ISOFORM BETA)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS ALPHA AND BETA)</scope>
<scope>TISSUE SPECIFICITY (ISOFORM BETA)</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="28471" last="28478">
<title>The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U.</title>
<authorList>
<person name="Eggert M."/>
<person name="Michel J."/>
<person name="Schneider S."/>
<person name="Bornfleth H."/>
<person name="Baniahmad A."/>
<person name="Fackelmayer F.O."/>
<person name="Schmidt S."/>
<person name="Renkawitz R."/>
</authorList>
<dbReference type="PubMed" id="9353307"/>
<dbReference type="DOI" id="10.1074/jbc.272.45.28471"/>
</citation>
<scope>INTERACTION WITH HNRNPU</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="3065" last="3073">
<title>Role of the Ada adaptor complex in gene activation by the glucocorticoid receptor.</title>
<authorList>
<person name="Henriksson A."/>
<person name="Almloef T."/>
<person name="Ford J."/>
<person name="McEwan I.J."/>
<person name="Gustafsson J.-A."/>
<person name="Wright A.P.H."/>
</authorList>
<dbReference type="PubMed" id="9154805"/>
<dbReference type="DOI" id="10.1128/mcb.17.6.3065"/>
</citation>
<scope>INTERACTION WITH TADA2L AND THE ADA COMPLEX</scope>
<scope>MUTAGENESIS OF PHE-191; ILE-193; LEU-194; LEU-197; TRP-213; LEU-224; LEU-225; PHE-235 AND LEU-236</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1998" name="Nature" volume="393" first="88" last="91">
<title>Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.</title>
<authorList>
<person name="Fryer C.J."/>
<person name="Archer T.K."/>
</authorList>
<dbReference type="PubMed" id="9590696"/>
<dbReference type="DOI" id="10.1038/30032"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH THE SMARCA4 COMPLEX; NCOA1; NCOA2 AND THE CREBBP/EP300 COMPLEX</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1999" name="J. Cell Biol." volume="146" first="929" last="940">
<title>A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity.</title>
<authorList>
<person name="Schneikert J."/>
<person name="Huebner S."/>
<person name="Martin E."/>
<person name="Cato A.B.C."/>
</authorList>
<dbReference type="PubMed" id="10477749"/>
<dbReference type="DOI" id="10.1083/jcb.146.5.929"/>
</citation>
<scope>INTERACTION WITH BAG1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1999" name="J. Clin. Endocrinol. Metab." volume="84" first="4283" last="4286">
<title>Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing.</title>
<authorList>
<person name="Rivers C."/>
<person name="Levy A."/>
<person name="Hancock J."/>
<person name="Lightman S."/>
<person name="Norman M."/>
</authorList>
<dbReference type="PubMed" id="10566686"/>
<dbReference type="DOI" id="10.1210/jcem.84.11.6235"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORMS ALPHA-2 AND BETA-2)</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="2519" last="2525">
<title>Steroidogenic enzyme gene expression in the human heart.</title>
<authorList>
<person name="Kayes-Wandover K.M."/>
<person name="White P.C."/>
</authorList>
<dbReference type="PubMed" id="10902803"/>
<dbReference type="DOI" id="10.1210/jcem.85.7.6663"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="5048" last="5063">
<title>A new family of nuclear receptor coregulators that integrates nuclear receptor signaling through CBP.</title>
<authorList>
<person name="Mahajan M.A."/>
<person name="Samuels H.H."/>
</authorList>
<dbReference type="PubMed" id="10866662"/>
<dbReference type="DOI" id="10.1128/mcb.20.14.5048-5063.2000"/>
</citation>
<scope>INTERACTION WITH NCOA6</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="657" last="661">
<title>Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor.</title>
<authorList>
<person name="Diamond M.I."/>
<person name="Robinson M.R."/>
<person name="Yamamoto K.R."/>
</authorList>
<dbReference type="PubMed" id="10639135"/>
<dbReference type="DOI" id="10.1073/pnas.97.2.657"/>
</citation>
<scope>EFFECT ON EXPANDED POLYGLUTAMINE PROTEIN</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="3937" last="3941">
<title>Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells.</title>
<authorList>
<person name="de Lange P."/>
<person name="Segeren C.M."/>
<person name="Koper J.W."/>
<person name="Wiemer E."/>
<person name="Sonneveld P."/>
<person name="Brinkmann A.O."/>
<person name="White A."/>
<person name="Brogan I.J."/>
<person name="de Jong F.H."/>
<person name="Lamberts S.W."/>
</authorList>
<dbReference type="PubMed" id="11358809"/>
</citation>
<scope>FUNCTION (ISOFORM GR-P)</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="42714" last="42721">
<title>Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.</title>
<authorList>
<person name="Wallace A.D."/>
<person name="Cidlowski J.A."/>
</authorList>
<dbReference type="PubMed" id="11555652"/>
<dbReference type="DOI" id="10.1074/jbc.m106033200"/>
</citation>
<scope>GLUCOCORTICOID-MEDIATED DOWN-REGULATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2001" name="J. Exp. Med." volume="193" first="585" last="593">
<title>High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids.</title>
<authorList>
<person name="Strickland I."/>
<person name="Kisich K."/>
<person name="Hauk P.J."/>
<person name="Vottero A."/>
<person name="Chrousos G.P."/>
<person name="Klemm D.J."/>
<person name="Leung D.Y.M."/>
</authorList>
<dbReference type="PubMed" id="11238589"/>
<dbReference type="DOI" id="10.1084/jem.193.5.585"/>
</citation>
<scope>REDUCTION OF CELL DEATH IN RESPONSE TO CORTICOSTEROIDS</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2001" name="Mol. Endocrinol." volume="15" first="1093" last="1103">
<title>Molecular identification and characterization of A and B forms of the glucocorticoid receptor.</title>
<authorList>
<person name="Yudt M.R."/>
<person name="Cidlowski J.A."/>
</authorList>
<dbReference type="PubMed" id="11435610"/>
<dbReference type="DOI" id="10.1210/mend.15.7.0667"/>
</citation>
<scope>FUNCTION (ISOFORMS ALPHA AND ALPHA-B)</scope>
<scope>ALTERNATIVE INITIATION</scope>
<scope>MUTAGENESIS OF MET-1 AND MET-27</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="6865" last="6870">
<title>Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.</title>
<authorList>
<person name="Webster J.C."/>
<person name="Oakley R.H."/>
<person name="Jewell C.M."/>
<person name="Cidlowski J.A."/>
</authorList>
<dbReference type="PubMed" id="11381138"/>
<dbReference type="DOI" id="10.1073/pnas.121455098"/>
</citation>
<scope>INDUCTION (ISOFORMS ALPHA AND BETA)</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2002" name="Biochem. J." volume="367" first="907" last="911">
<title>Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.</title>
<authorList>
<person name="Tian S."/>
<person name="Poukka H."/>
<person name="Palvimo J.J."/>
<person name="Jaenne O.A."/>
</authorList>
<dbReference type="PubMed" id="12144530"/>
<dbReference type="DOI" id="10.1042/bj20021085"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>MUTAGENESIS OF LYS-277; LYS-293 AND LYS-703</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="26573" last="26580">
<title>Deciphering the phosphorylation 'code' of the glucocorticoid receptor in vivo.</title>
<authorList>
<person name="Wang Z."/>
<person name="Frederick J."/>
<person name="Garabedian M.J."/>
</authorList>
<dbReference type="PubMed" id="12000743"/>
<dbReference type="DOI" id="10.1074/jbc.m110530200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-203 AND SER-211</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="14783" last="14788">
<title>Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade.</title>
<authorList>
<person name="Wong C.-W."/>
<person name="McNally C."/>
<person name="Nickbarg E."/>
<person name="Komm B.S."/>
<person name="Cheskis B.J."/>
</authorList>
<dbReference type="PubMed" id="12415108"/>
<dbReference type="DOI" id="10.1073/pnas.192569699"/>
</citation>
<scope>INTERACTION WITH PELP1</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="Ann. N. Y. Acad. Sci." volume="1024" first="102" last="123">
<title>The origin and functions of multiple human glucocorticoid receptor isoforms.</title>
<authorList>
<person name="Lu N.Z."/>
<person name="Cidlowski J.A."/>
</authorList>
<dbReference type="PubMed" id="15265776"/>
<dbReference type="DOI" id="10.1196/annals.1321.008"/>
</citation>
<scope>REVIEW ON ALTERNATIVE SPLICING</scope>
<scope>ALTERNATIVE INITIATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2004" name="J. Cell. Biochem." volume="92" first="810" last="819">
<title>Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation.</title>
<authorList>
<person name="Guerrero-Santoro J."/>
<person name="Yang L."/>
<person name="Stallcup M.R."/>
<person name="DeFranco D.B."/>
</authorList>
<dbReference type="PubMed" id="15211577"/>
<dbReference type="DOI" id="10.1002/jcb.20109"/>
</citation>
<scope>INTERACTION WITH TGFB1I1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2005" name="Mol. Cell" volume="18" first="331" last="342">
<title>Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.</title>
<authorList>
<person name="Lu N.Z."/>
<person name="Cidlowski J.A."/>
</authorList>
<dbReference type="PubMed" id="15866175"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.03.025"/>
</citation>
<scope>FUNCTION (ISOFORMS ALPHA; ALPHA-B; ALPHA-C1; ALPHA-C2; ALPHA-C3; ALPHA-D1; ALPHA-D2 AND ALPHA-D3)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM ALPHA-B)</scope>
<scope>ALTERNATIVE INITIATION (ISOFORMS ALPHA; ALPHA-B; ALPHA-C1; ALPHA-C2; ALPHA-C3; ALPHA-D1; ALPHA-D2 AND ALPHA-D3)</scope>
<scope>MUTAGENESIS OF MET-1; MET-27; MET-86; MET-90; MET-98; MET-316; MET-331 AND MET-336</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2005" name="Mol. Endocrinol." volume="19" first="885" last="897">
<title>Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.</title>
<authorList>
<person name="Martens C."/>
<person name="Bilodeau S."/>
<person name="Maira M."/>
<person name="Gauthier Y."/>
<person name="Drouin J."/>
</authorList>
<dbReference type="PubMed" id="15591535"/>
<dbReference type="DOI" id="10.1210/me.2004-0333"/>
</citation>
<scope>INTERACTION WITH NR4A3</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="8555" last="8560">
<title>HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.</title>
<authorList>
<person name="Shimizu N."/>
<person name="Ouchida R."/>
<person name="Yoshikawa N."/>
<person name="Hisada T."/>
<person name="Watanabe H."/>
<person name="Okamoto K."/>
<person name="Kusuhara M."/>
<person name="Handa H."/>
<person name="Morimoto C."/>
<person name="Tanaka H."/>
</authorList>
<dbReference type="PubMed" id="15941832"/>
<dbReference type="DOI" id="10.1073/pnas.0409863102"/>
</citation>
<scope>INTERACTION WITH HEXIM1</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2006" name="Biochem. Biophys. Res. Commun." volume="348" first="1239" last="1244">
<title>Functional interaction between the glucocorticoid receptor and GANP/MCM3AP.</title>
<authorList>
<person name="Osman W."/>
<person name="Laine S."/>
<person name="Zilliacus J."/>
</authorList>
<dbReference type="PubMed" id="16914116"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.07.182"/>
</citation>
<scope>INTERACTION WITH MCM3AP</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="1722" last="1730">
<title>GCUNC-45 is a novel regulator for the progesterone receptor/hsp90 chaperoning pathway.</title>
<authorList>
<person name="Chadli A."/>
<person name="Graham J.D."/>
<person name="Abel M.G."/>
<person name="Jackson T.A."/>
<person name="Gordon D.F."/>
<person name="Wood W.M."/>
<person name="Felts S.J."/>
<person name="Horwitz K.B."/>
<person name="Toft D."/>
</authorList>
<dbReference type="PubMed" id="16478993"/>
<dbReference type="DOI" id="10.1128/mcb.26.5.1722-1730.2006"/>
</citation>
<scope>INTERACTION WITH UNC45A</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="7309" last="7322">
<title>Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles.</title>
<authorList>
<person name="Galliher-Beckley A.J."/>
<person name="Williams J.G."/>
<person name="Collins J.B."/>
<person name="Cidlowski J.A."/>
</authorList>
<dbReference type="PubMed" id="18838540"/>
<dbReference type="DOI" id="10.1128/mcb.00808-08"/>
</citation>
<scope>INTERACTION WITH GSK3B</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM ALPHA)</scope>
<scope>PHOSPHORYLATION AT SER-404</scope>
<scope>MUTAGENESIS OF SER-404</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="Mol. Endocrinol." volume="22" first="1754" last="1766">
<title>Glucocorticoid receptor phosphorylation differentially affects target gene expression.</title>
<authorList>
<person name="Chen W."/>
<person name="Dang T."/>
<person name="Blind R.D."/>
<person name="Wang Z."/>
<person name="Cavasotto C.N."/>
<person name="Hittelman A.B."/>
<person name="Rogatsky I."/>
<person name="Logan S.K."/>
<person name="Garabedian M.J."/>
</authorList>
<dbReference type="PubMed" id="18483179"/>
<dbReference type="DOI" id="10.1210/me.2007-0219"/>
</citation>
<scope>PHOSPHORYLATION AT SER-203; SER-211 AND SER-226</scope>
<scope>MUTAGENESIS OF SER-211 AND SER-226</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; SER-226 AND SER-267</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2009" name="Biochem. Biophys. Res. Commun." volume="381" first="671" last="675">
<title>Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity.</title>
<authorList>
<person name="Kino T."/>
<person name="Manoli I."/>
<person name="Kelkar S."/>
<person name="Wang Y."/>
<person name="Su Y.A."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="19248771"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2009.02.110"/>
</citation>
<scope>FUNCTION (ISOFORMS ALPHA AND BETA)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM BETA)</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2009" name="FASEB J." volume="23" first="1572" last="1583">
<title>Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications.</title>
<authorList>
<person name="Nader N."/>
<person name="Chrousos G.P."/>
<person name="Kino T."/>
</authorList>
<dbReference type="PubMed" id="19141540"/>
<dbReference type="DOI" id="10.1096/fj.08-117697"/>
</citation>
<scope>FUNCTION (ISOFORM ALPHA)</scope>
<scope>ACETYLATION AT LYS-480; LYS-492; LYS-494 AND LYS-495</scope>
<scope>MUTAGENESIS OF LYS-480; LYS-492; LYS-494 AND LYS-495</scope>
<scope>INTERACTION WITH CLOCK</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="51">
<citation type="journal article" date="2010" name="BMC Mol. Biol." volume="11" first="3" last="3">
<title>The transforming acidic coiled coil (TACC1) protein modulates the transcriptional activity of the nuclear receptors TR and RAR.</title>
<authorList>
<person name="Guyot R."/>
<person name="Vincent S."/>
<person name="Bertin J."/>
<person name="Samarut J."/>
<person name="Ravel-Chapuis P."/>
</authorList>
<dbReference type="PubMed" id="20078863"/>
<dbReference type="DOI" id="10.1186/1471-2199-11-3"/>
</citation>
<scope>INTERACTION WITH TACC1</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2010" name="Endocrinology" volume="151" first="3204" last="3213">
<title>Glucocorticoid receptor-beta and receptor-gamma exert dominant negative effect on gene repression but not on gene induction.</title>
<authorList>
<person name="Taniguchi Y."/>
<person name="Iwasaki Y."/>
<person name="Tsugita M."/>
<person name="Nishiyama M."/>
<person name="Taguchi T."/>
<person name="Okazaki M."/>
<person name="Nakayama S."/>
<person name="Kambayashi M."/>
<person name="Hashimoto K."/>
<person name="Terada Y."/>
</authorList>
<dbReference type="PubMed" id="20484466"/>
<dbReference type="DOI" id="10.1210/en.2009-1254"/>
</citation>
<scope>FUNCTION (ISOFORMS ALPHA; BETA; ALPHA-2 AND 10)</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="54">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2011" name="Biochim. Biophys. Acta" volume="1813" first="1814" last="1821">
<title>Glucocorticoids induce mitochondrial gene transcription in HepG2 cells: role of the mitochondrial glucocorticoid receptor.</title>
<authorList>
<person name="Psarra A.M."/>
<person name="Sekeris C.E."/>
</authorList>
<dbReference type="PubMed" id="21664385"/>
<dbReference type="DOI" id="10.1016/j.bbamcr.2011.05.014"/>
</citation>
<scope>FUNCTION (ISOFORM ALPHA)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM ALPHA)</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="30152" last="30160">
<title>The 90-kDa heat-shock protein (Hsp90)-binding immunophilin FKBP51 is a mitochondrial protein that translocates to the nucleus to protect cells against oxidative stress.</title>
<authorList>
<person name="Gallo L.I."/>
<person name="Lagadari M."/>
<person name="Piwien-Pilipuk G."/>
<person name="Galigniana M.D."/>
</authorList>
<dbReference type="PubMed" id="21730050"/>
<dbReference type="DOI" id="10.1074/jbc.m111.256610"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2011" name="Nature" volume="480" first="552" last="556">
<title>Cryptochromes mediate rhythmic repression of the glucocorticoid receptor.</title>
<authorList>
<person name="Lamia K.A."/>
<person name="Papp S.J."/>
<person name="Yu R.T."/>
<person name="Barish G.D."/>
<person name="Uhlenhaut N.H."/>
<person name="Jonker J.W."/>
<person name="Downes M."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="22170608"/>
<dbReference type="DOI" id="10.1038/nature10700"/>
</citation>
<scope>INTERACTION WITH CRY1 AND CRY2</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E25612" last="E25612">
<title>Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man.</title>
<authorList>
<person name="Charmandari E."/>
<person name="Chrousos G.P."/>
<person name="Lambrou G.I."/>
<person name="Pavlaki A."/>
<person name="Koide H."/>
<person name="Ng S.S."/>
<person name="Kino T."/>
</authorList>
<dbReference type="PubMed" id="21980503"/>
<dbReference type="DOI" id="10.1371/journal.pone.0025612"/>
</citation>
<scope>ACETYLATION</scope>
<scope>INTERACTION WITH CLOCK</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORMS ALPHA-B AND BETA-B)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2013" name="Cell Death Dis." volume="4" first="E453" last="E453">
<title>Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes.</title>
<authorList>
<person name="Wu I."/>
<person name="Shin S.C."/>
<person name="Cao Y."/>
<person name="Bender I.K."/>
<person name="Jafari N."/>
<person name="Feng G."/>
<person name="Lin S."/>
<person name="Cidlowski J.A."/>
<person name="Schleimer R.P."/>
<person name="Lu N.Z."/>
</authorList>
<dbReference type="PubMed" id="23303127"/>
<dbReference type="DOI" id="10.1038/cddis.2012.193"/>
</citation>
<scope>FUNCTION (ISOFORMS ALPHA; ALPHA-C3 AND ALPHA-D3)</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-8; SER-45 AND SER-267</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="62">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="2116" last="2127">
<title>RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity.</title>
<authorList>
<person name="Druker J."/>
<person name="Liberman A.C."/>
<person name="Antunica-Noguerol M."/>
<person name="Gerez J."/>
<person name="Paez-Pereda M."/>
<person name="Rein T."/>
<person name="Iniguez-Lluhi J.A."/>
<person name="Holsboer F."/>
<person name="Arzt E."/>
</authorList>
<dbReference type="PubMed" id="23508108"/>
<dbReference type="DOI" id="10.1128/mcb.01470-12"/>
</citation>
<scope>MUTAGENESIS OF LYS-703</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2013" name="Mol. Endocrinol." volume="27" first="1577" last="1587">
<title>Determinants of the heightened activity of glucocorticoid receptor translational isoforms.</title>
<authorList>
<person name="Bender I.K."/>
<person name="Cao Y."/>
<person name="Lu N.Z."/>
</authorList>
<dbReference type="PubMed" id="23820903"/>
<dbReference type="DOI" id="10.1210/me.2013-1009"/>
</citation>
<scope>FUNCTION (ISOFORMS ALPHA; ALPHA-C3 AND ALPHA-D3)</scope>
<scope>MUTAGENESIS OF ASP-101; 106-GLN-GLN-107 AND 113-SER-SER-114</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="65">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-293</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2015" name="Mol. Cell. Biol." volume="36" first="714" last="730">
<title>Human Glucocorticoid Receptor beta (hGRbeta) Regulates Gluconeogenesis and Inflammation in Mouse Liver.</title>
<authorList>
<person name="He B."/>
<person name="Cruz-Topete D."/>
<person name="Oakley R.H."/>
<person name="Xiao X."/>
<person name="Cidlowski J.A."/>
</authorList>
<dbReference type="PubMed" id="26711253"/>
<dbReference type="DOI" id="10.1128/mcb.00908-15"/>
</citation>
<scope>FUNCTION (ISOFORM BETA)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM BETA)</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="E1540" last="E1549">
<title>Glucocorticoid receptor interacts with PNRC2 in a ligand-dependent manner to recruit UPF1 for rapid mRNA degradation.</title>
<authorList>
<person name="Cho H."/>
<person name="Park O.H."/>
<person name="Park J."/>
<person name="Ryu I."/>
<person name="Kim J."/>
<person name="Ko J."/>
<person name="Kim Y.K."/>
</authorList>
<dbReference type="PubMed" id="25775514"/>
<dbReference type="DOI" id="10.1073/pnas.1409612112"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PNRC2</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="5479" last="5484">
<title>Glucocorticoid receptor regulates accurate chromosome segregation and is associated with malignancy.</title>
<authorList>
<person name="Matthews L.C."/>
<person name="Berry A.A."/>
<person name="Morgan D.J."/>
<person name="Poolman T.M."/>
<person name="Bauer K."/>
<person name="Kramer F."/>
<person name="Spiller D.G."/>
<person name="Richardson R.V."/>
<person name="Chapman K.E."/>
<person name="Farrow S.N."/>
<person name="Norman M.R."/>
<person name="Williamson A.J."/>
<person name="Whetton A.D."/>
<person name="Taylor S.S."/>
<person name="Tuckermann J.P."/>
<person name="White M.R."/>
<person name="Ray D.W."/>
</authorList>
<dbReference type="PubMed" id="25847991"/>
<dbReference type="DOI" id="10.1073/pnas.1411356112"/>
</citation>
<scope>FUNCTION (ISOFORM ALPHA)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM ALPHA)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DOMAIN</scope>
<scope>PHOSPHORYLATION AT SER-203 AND SER-211</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="12037" last="12037">
<title>The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding.</title>
<authorList>
<person name="Woodford M.R."/>
<person name="Dunn D.M."/>
<person name="Blanden A.R."/>
<person name="Capriotti D."/>
<person name="Loiselle D."/>
<person name="Prodromou C."/>
<person name="Panaretou B."/>
<person name="Hughes P.F."/>
<person name="Smith A."/>
<person name="Ackerman W."/>
<person name="Haystead T.A."/>
<person name="Loh S.N."/>
<person name="Bourboulia D."/>
<person name="Schmidt L.S."/>
<person name="Marston Linehan W."/>
<person name="Bratslavsky G."/>
<person name="Mollapour M."/>
</authorList>
<dbReference type="PubMed" id="27353360"/>
<dbReference type="DOI" id="10.1038/ncomms12037"/>
</citation>
<scope>INTERACTION WITH FNIP1 AND FNIP2</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2017" name="EMBO J." volume="36" first="3650" last="3665">
<title>Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients.</title>
<authorList>
<person name="Woodford M.R."/>
<person name="Sager R.A."/>
<person name="Marris E."/>
<person name="Dunn D.M."/>
<person name="Blanden A.R."/>
<person name="Murphy R.L."/>
<person name="Rensing N."/>
<person name="Shapiro O."/>
<person name="Panaretou B."/>
<person name="Prodromou C."/>
<person name="Loh S.N."/>
<person name="Gutmann D.H."/>
<person name="Bourboulia D."/>
<person name="Bratslavsky G."/>
<person name="Wong M."/>
<person name="Mollapour M."/>
</authorList>
<dbReference type="PubMed" id="29127155"/>
<dbReference type="DOI" id="10.15252/embj.201796700"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH HSP90; HSP70; CDC37; PPP5C; TSC1; TSC2; AKT; CDK4 AND RAF1</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-258 AND LYS-277</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2002" name="Cell" volume="110" first="93" last="105">
<title>Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.</title>
<authorList>
<person name="Bledsoe R.K."/>
<person name="Montana V.G."/>
<person name="Stanley T.B."/>
<person name="Delves C.J."/>
<person name="Apolito C.J."/>
<person name="McKee D.D."/>
<person name="Consler T.G."/>
<person name="Parks D.J."/>
<person name="Stewart E.L."/>
<person name="Willson T.M."/>
<person name="Lambert M.H."/>
<person name="Moore J.T."/>
<person name="Pearce K.H."/>
<person name="Xu H.E."/>
</authorList>
<dbReference type="PubMed" id="12151000"/>
<dbReference type="DOI" id="10.1016/s0092-8674(02)00817-6"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 521-777 OF MUTANT SER-602 IN COMPLEX WITH NCOA2; DEXAMETHASONE AND RU-486</scope>
<scope>MUTAGENESIS OF ARG-585; ASP-590; PHE-602; PRO-625 AND ILE-628</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="22748" last="22754">
<title>The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism.</title>
<authorList>
<person name="Kauppi B."/>
<person name="Jakob C."/>
<person name="Faernegaardh M."/>
<person name="Yang J."/>
<person name="Ahola H."/>
<person name="Alarcon M."/>
<person name="Calles K."/>
<person name="Engstrom O."/>
<person name="Harlan J."/>
<person name="Muchmore S."/>
<person name="Ramqvist A.-K."/>
<person name="Thorell S."/>
<person name="Oehman L."/>
<person name="Greer J."/>
<person name="Gustafsson J.-A."/>
<person name="Carlstedt-Duke J."/>
<person name="Carlquist M."/>
</authorList>
<dbReference type="PubMed" id="12686538"/>
<dbReference type="DOI" id="10.1074/jbc.m212711200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 500-777 OF MUTANT SER-602 IN COMPLEX WITH COACTIVATOR PEPTIDE; DEXAMETHASONE AND WITH RU-486</scope>
</reference>
<reference key="74">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="87" first="680" last="686">
<title>Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance.</title>
<authorList>
<person name="Hurley D.M."/>
<person name="Accili D."/>
<person name="Stratakis C.A."/>
<person name="Karl M."/>
<person name="Vamvakopoulos N."/>
<person name="Rorer E."/>
<person name="Constantine K."/>
<person name="Taylor S.I."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="1704018"/>
<dbReference type="DOI" id="10.1172/jci115046"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT GCCR VAL-641</scope>
</reference>
<reference key="75">
<citation type="journal article" date="1993" name="Cancer Res." volume="53" first="4059" last="4065">
<title>Cloning and expression of mutant glucocorticoid receptors from glucocorticoid-sensitive and -resistant human leukemic cells.</title>
<authorList>
<person name="Powers J.H."/>
<person name="Hillmann A.G."/>
<person name="Tang D.C."/>
<person name="Harmon J.M."/>
</authorList>
<dbReference type="PubMed" id="8358735"/>
</citation>
<scope>VARIANTS TYR-421 AND PHE-753</scope>
</reference>
<reference key="76">
<citation type="journal article" date="1993" name="J. Clin. Endocrinol. Metab." volume="76" first="683" last="689">
<title>Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene.</title>
<authorList>
<person name="Karl M."/>
<person name="Lamberts S.W.J."/>
<person name="Detera-Wadleigh S.D."/>
<person name="Encio I.J."/>
<person name="Stratakis C.A."/>
<person name="Hurley D.M."/>
<person name="Accili D."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="8445027"/>
<dbReference type="DOI" id="10.1210/jcem.76.3.8445027"/>
</citation>
<scope>VARIANT SER-363</scope>
</reference>
<reference key="77">
<citation type="journal article" date="1993" name="J. Clin. Invest." volume="91" first="1918" last="1925">
<title>A mutation of the glucocorticoid receptor in primary cortisol resistance.</title>
<authorList>
<person name="Malchoff D.M."/>
<person name="Brufsky A."/>
<person name="Reardon G."/>
<person name="McDermott P."/>
<person name="Javier E.C."/>
<person name="Bergh C.H."/>
<person name="Rowe D."/>
<person name="Malchoff C.D."/>
</authorList>
<dbReference type="PubMed" id="7683692"/>
<dbReference type="DOI" id="10.1172/jci116410"/>
</citation>
<scope>VARIANT GCCR ILE-729</scope>
</reference>
<reference key="78">
<citation type="journal article" date="1993" name="Mol. Endocrinol." volume="7" first="631" last="642">
<title>Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes.</title>
<authorList>
<person name="Ashraf J."/>
<person name="Thompson E.B."/>
</authorList>
<dbReference type="PubMed" id="8316249"/>
<dbReference type="DOI" id="10.1210/mend.7.5.8316249"/>
</citation>
<scope>VARIANT PHE-753</scope>
</reference>
<reference key="79">
<citation type="journal article" date="1997" name="Hum. Genet." volume="99" first="663" last="668">
<title>Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance.</title>
<authorList>
<person name="Koper J.W."/>
<person name="Stolk R.P."/>
<person name="de Lange P."/>
<person name="Huizenga N.A.T.M."/>
<person name="Molijn G.-J."/>
<person name="Pols H.A.P."/>
<person name="Grobbee D.E."/>
<person name="Karl M."/>
<person name="de Jong F.H."/>
<person name="Brinkmann A.O."/>
<person name="Lamberts S.W.J."/>
</authorList>
<dbReference type="PubMed" id="9150737"/>
<dbReference type="DOI" id="10.1007/s004390050425"/>
</citation>
<scope>VARIANTS LYS-23 AND SER-363</scope>
</reference>
<reference key="80">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="231" last="238">
<title>Characterization of single-nucleotide polymorphisms in coding regions of human genes.</title>
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="10391209"/>
<dbReference type="DOI" id="10.1038/10290"/>
</citation>
<scope>VARIANTS LYS-23; VAL-65 AND SER-363</scope>
</reference>
<reference key="81">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="373" last="373">
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:10391209</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2000" name="Am. J. Med. Genet." volume="96" first="412" last="417">
<title>Five missense variants in the amino-terminal domain of the glucocorticoid receptor: no association with puerperal psychosis or schizophrenia.</title>
<authorList>
<person name="Feng J."/>
<person name="Zheng J."/>
<person name="Bennett W.P."/>
<person name="Heston L.L."/>
<person name="Jones I.R."/>
<person name="Craddock N."/>
<person name="Sommer S.S."/>
</authorList>
<dbReference type="PubMed" id="10898924"/>
<dbReference type="DOI" id="10.1002/1096-8628(20000612)96:3&lt;412::aid-ajmg33>3.0.co;2-c"/>
</citation>
<scope>VARIANTS LYS-23; LEU-29; PHE-112; ASN-233 AND SER-363</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2001" name="Clin. Endocrinol. (Oxf.)" volume="55" first="363" last="371">
<title>Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.</title>
<authorList>
<person name="Ruiz M."/>
<person name="Lind U."/>
<person name="Gaafvels M."/>
<person name="Eggertsen G."/>
<person name="Carlstedt-Duke J."/>
<person name="Nilsson L."/>
<person name="Holtmann M."/>
<person name="Stierna P."/>
<person name="Wikstroem A.-C."/>
<person name="Werner S."/>
</authorList>
<dbReference type="PubMed" id="11589680"/>
<dbReference type="DOI" id="10.1046/j.1365-2265.2001.01323.x"/>
</citation>
<scope>VARIANTS GCCR HIS-477 AND SER-679</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2001" name="J. Clin. Endocrinol. Metab." volume="86" first="2270" last="2274">
<title>The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus.</title>
<authorList>
<person name="Dobson M.G."/>
<person name="Redfern C.P.F."/>
<person name="Unwin N."/>
<person name="Weaver J.U."/>
</authorList>
<dbReference type="PubMed" id="11344238"/>
<dbReference type="DOI" id="10.1210/jcem.86.5.7465"/>
</citation>
<scope>VARIANT SER-363</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2001" name="J. Clin. Endocrinol. Metab." volume="86" first="5600" last="5608">
<title>Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.</title>
<authorList>
<person name="Kino T."/>
<person name="Stauber R.H."/>
<person name="Resau J.H."/>
<person name="Pavlakis G.N."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="11701741"/>
<dbReference type="DOI" id="10.1210/jcem.86.11.8017"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT GCCR ASN-559</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2002" name="Diabetes" volume="51" first="3128" last="3134">
<title>A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels.</title>
<authorList>
<person name="van Rossum E.F.C."/>
<person name="Koper J.W."/>
<person name="Huizenga N.A.T.M."/>
<person name="Uitterlinden A.G."/>
<person name="Janssen J.A.M.J.L."/>
<person name="Brinkmann A.O."/>
<person name="Grobbee D.E."/>
<person name="de Jong F.H."/>
<person name="van Duyn C.M."/>
<person name="Pols H.A.P."/>
<person name="Lamberts S.W.J."/>
</authorList>
<dbReference type="PubMed" id="12351458"/>
<dbReference type="DOI" id="10.2337/diabetes.51.10.3128"/>
</citation>
<scope>VARIANT LYS-23</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="1805" last="1809">
<title>Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene.</title>
<authorList>
<person name="Mendonca B.B."/>
<person name="Leite M.V."/>
<person name="de Castro M."/>
<person name="Kino T."/>
<person name="Elias L.L.K."/>
<person name="Bachega T.A.S."/>
<person name="Arnhold I.J.P."/>
<person name="Chrousos G.P."/>
<person name="Latronico A.C."/>
</authorList>
<dbReference type="PubMed" id="11932321"/>
<dbReference type="DOI" id="10.1210/jcem.87.4.8379"/>
</citation>
<scope>VARIANT PSEUDOHERMAPHRODITISM ALA-571</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="2658" last="2667">
<title>A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.</title>
<authorList>
<person name="Vottero A."/>
<person name="Kino T."/>
<person name="Combe H."/>
<person name="Lecomte P."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="12050230"/>
<dbReference type="DOI" id="10.1210/jcem.87.6.8520"/>
</citation>
<scope>VARIANT GCCR MET-747</scope>
<scope>ALTERED INTERACTION WITH THE COACTIVATOR NCOA2</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2004" name="Am. J. Med." volume="117" first="158" last="162">
<title>Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men.</title>
<authorList>
<person name="van Rossum E.F.C."/>
<person name="Feelders R.A."/>
<person name="van den Beld A.W."/>
<person name="Uitterlinden A.G."/>
<person name="Janssen J.A.M.J.L."/>
<person name="Ester W."/>
<person name="Brinkmann A.O."/>
<person name="Grobbee D.E."/>
<person name="de Jong F.H."/>
<person name="Pols H.A.P."/>
<person name="Koper J.W."/>
<person name="Lamberts S.W.J."/>
</authorList>
<dbReference type="PubMed" id="15276593"/>
<dbReference type="DOI" id="10.1016/j.amjmed.2004.01.027"/>
</citation>
<scope>VARIANT LYS-23</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2004" name="J. Clin. Endocrinol. Metab." volume="89" first="4004" last="4009">
<title>The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults.</title>
<authorList>
<person name="van Rossum E.F.C."/>
<person name="Voorhoeve P.G."/>
<person name="te Velde S.J."/>
<person name="Koper J.W."/>
<person name="Delemarre-van de Waal H.A."/>
<person name="Kemper H.C.G."/>
<person name="Lamberts S.W.J."/>
</authorList>
<dbReference type="PubMed" id="15292341"/>
<dbReference type="DOI" id="10.1210/jc.2003-031422"/>
</citation>
<scope>VARIANT LYS-23</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="3696" last="3705">
<title>A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.</title>
<authorList>
<person name="Charmandari E."/>
<person name="Raji A."/>
<person name="Kino T."/>
<person name="Ichijo T."/>
<person name="Tiulpakov A."/>
<person name="Zachman K."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="15769988"/>
<dbReference type="DOI" id="10.1210/jc.2004-1920"/>
</citation>
<scope>VARIANT GCCR PRO-773</scope>
<scope>CHARACTERIZATION OF VARIANT GCCR PRO-773</scope>
<scope>INVOLVEMENT IN GCCR</scope>
<scope>FUNCTION (ISOFORM ALPHA)</scope>
<scope>INTERACTION WITH GRIP1</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM ALPHA)</scope>
</reference>
<reference key="92">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="5804" last="5810">
<title>Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression.</title>
<authorList>
<person name="Russcher H."/>
<person name="Smit P."/>
<person name="van den Akker E.L."/>
<person name="van Rossum E.F."/>
<person name="Brinkmann A.O."/>
<person name="de Jong F.H."/>
<person name="Lamberts S.W."/>
<person name="Koper J.W."/>
</authorList>
<dbReference type="PubMed" id="16030164"/>
<dbReference type="DOI" id="10.1210/jc.2005-0646"/>
</citation>
<scope>VARIANTS LYS-23 AND SER-363</scope>
<scope>CHARACTERIZATION OF VARIANTS LYS-23 AND SER-363</scope>
</reference>
<reference key="93">
<citation type="journal article" date="2007" name="J. Clin. Endocrinol. Metab." volume="92" first="3986" last="3990">
<title>A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.</title>
<authorList>
<person name="Charmandari E."/>
<person name="Kino T."/>
<person name="Ichijo T."/>
<person name="Jubiz W."/>
<person name="Mejia L."/>
<person name="Zachman K."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="17635946"/>
<dbReference type="DOI" id="10.1210/jc.2006-2830"/>
</citation>
<scope>VARIANT GCCR LEU-737</scope>
<scope>CHARACTERIZATION OF VARIANT GCCR LEU-737</scope>
<scope>FUNCTION (ISOFORM ALPHA)</scope>
<scope>INTERACTION WITH GRIP1</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM ALPHA)</scope>
</reference>
<reference key="94">
<citation type="journal article" date="2010" name="J. Clin. Endocrinol. Metab." volume="95" first="2281" last="2285">
<title>A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.</title>
<authorList>
<person name="Nader N."/>
<person name="Bachrach B.E."/>
<person name="Hurt D.E."/>
<person name="Gajula S."/>
<person name="Pittman A."/>
<person name="Lescher R."/>
<person name="Kino T."/>
</authorList>
<dbReference type="PubMed" id="20335448"/>
<dbReference type="DOI" id="10.1210/jc.2009-2463"/>
</citation>
<scope>VARIANT GCCR GLN-714</scope>
<scope>CHARACTERIZATION OF VARIANT GCCR GLN-714</scope>
</reference>
<reference key="95">
<citation type="journal article" date="2011" name="Chin. Med. J." volume="124" first="551" last="555">
<title>Generalized glucocorticoid resistance accompanied with an adrenocortical adenoma and caused by a novel point mutation of human glucocorticoid receptor gene.</title>
<authorList>
<person name="Zhu H.J."/>
<person name="Dai Y.F."/>
<person name="Wang O."/>
<person name="Li M."/>
<person name="Lu L."/>
<person name="Zhao W.G."/>
<person name="Xing X.P."/>
<person name="Pan H."/>
<person name="Li N.S."/>
<person name="Gong F.Y."/>
</authorList>
<dbReference type="PubMed" id="21362280"/>
</citation>
<scope>VARIANT GCCR ILE-556</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2013" name="J. Clin. Endocrinol. Metab." volume="98" first="E790" last="E795">
<title>A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD.</title>
<authorList>
<person name="Roberts M.L."/>
<person name="Kino T."/>
<person name="Nicolaides N.C."/>
<person name="Hurt D.E."/>
<person name="Katsantoni E."/>
<person name="Sertedaki A."/>
<person name="Komianou F."/>
<person name="Kassiou K."/>
<person name="Chrousos G.P."/>
<person name="Charmandari E."/>
</authorList>
<dbReference type="PubMed" id="23426617"/>
<dbReference type="DOI" id="10.1210/jc.2012-3549"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT GCCR ALA-423</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2014" name="J. Clin. Endocrinol. Metab." volume="99" first="E902" last="E907">
<title>A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.</title>
<authorList>
<person name="Nicolaides N.C."/>
<person name="Roberts M.L."/>
<person name="Kino T."/>
<person name="Braatvedt G."/>
<person name="Hurt D.E."/>
<person name="Katsantoni E."/>
<person name="Sertedaki A."/>
<person name="Chrousos G.P."/>
<person name="Charmandari E."/>
</authorList>
<dbReference type="PubMed" id="24483153"/>
<dbReference type="DOI" id="10.1210/jc.2013-3005"/>
</citation>
<scope>VARIANT GCCR GLY-575</scope>
<scope>CHARACTERIZATION OF VARIANT GCCR GLY-575</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2015" name="Eur. J. Clin. Invest." volume="45" first="782" last="791">
<title>A novel mutation of the hGR gene causing Chrousos syndrome.</title>
<authorList>
<person name="Nicolaides N.C."/>
<person name="Geer E.B."/>
<person name="Vlachakis D."/>
<person name="Roberts M.L."/>
<person name="Psarra A.M."/>
<person name="Moutsatsou P."/>
<person name="Sertedaki A."/>
<person name="Kossida S."/>
<person name="Charmandari E."/>
</authorList>
<dbReference type="PubMed" id="26031419"/>
<dbReference type="DOI" id="10.1111/eci.12470"/>
</citation>
<scope>VARIANT GCCR ARG-726</scope>
<scope>CHARACTERIZATION OF VARIANT GCCR ARG-726</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2016" name="Eur. J. Clin. Invest." volume="46" first="42" last="49">
<title>Functional characterization of the hGRalphaT556I causing Chrousos syndrome.</title>
<authorList>
<person name="Nicolaides N.C."/>
<person name="Skyrla E."/>
<person name="Vlachakis D."/>
<person name="Psarra A.M."/>
<person name="Moutsatsou P."/>
<person name="Sertedaki A."/>
<person name="Kossida S."/>
<person name="Charmandari E."/>
</authorList>
<dbReference type="PubMed" id="26541474"/>
<dbReference type="DOI" id="10.1111/eci.12563"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT GCCR ILE-556</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2016" name="Hum. Mutat." volume="37" first="794" last="803">
<title>Three novel heterozygous point mutations of NR3C1 causing glucocorticoid resistance.</title>
<authorList>
<person name="Vitellius G."/>
<person name="Fagart J."/>
<person name="Delemer B."/>
<person name="Amazit L."/>
<person name="Ramos N."/>
<person name="Bouligand J."/>
<person name="Le Billan F."/>
<person name="Castinetti F."/>
<person name="Guiochon-Mantel A."/>
<person name="Trabado S."/>
<person name="Lombes M."/>
</authorList>
<dbReference type="PubMed" id="27120390"/>
<dbReference type="DOI" id="10.1002/humu.23008"/>
</citation>
<scope>VARIANTS GCCR SER-477; CYS-478 AND PRO-672</scope>
<scope>CHARACTERIZATION OF VARIANTS GCCR SER-477; CYS-478 AND CYS-478</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="16 71 76 90">Receptor for glucocorticoids (GC) (PubMed:27120390). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling (PubMed:9590696). Plays a role in rapid mRNA degradation by binding to the 5' UTR of target mRNAs and interacting with PNRC2 in a ligand-dependent manner which recruits the RNA helicase UPF1 and the mRNA-decapping enzyme DCP1A, leading to RNA decay (PubMed:25775514). Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform Alpha</molecule>
<text evidence="16 29 45 46 52 55 56 59 61 66 69 72">Has transcriptional activation and repression activity (PubMed:15866175, PubMed:19248771, PubMed:20484466, PubMed:23820903, PubMed:11435610, PubMed:15769988, PubMed:17635946, PubMed:19141540, PubMed:21664385). Mediates glucocorticoid-induced apoptosis (PubMed:23303127). Promotes accurate chromosome segregation during mitosis (PubMed:25847991). May act as a tumor suppressor (PubMed:25847991). May play a negative role in adipogenesis through the regulation of lipolytic and antilipogenic gene expression (By similarity).</text>
</comment>
<comment type="function">
<molecule>Isoform Beta</molecule>
<text evidence="16 56 59 75 81 86">Acts as a dominant negative inhibitor of isoform Alpha (PubMed:7769088, PubMed:8621628, PubMed:20484466). Has intrinsic transcriptional activity independent of isoform Alpha when both isoforms are coexpressed (PubMed:19248771, PubMed:26711253). Loses this transcription modulator function on its own (PubMed:20484466). Has no hormone-binding activity (PubMed:8621628). May play a role in controlling glucose metabolism by maintaining insulin sensitivity (By similarity). Reduces hepatic gluconeogenesis through down-regulation of PEPCK in an isoform Alpha-dependent manner (PubMed:26711253). Directly regulates STAT1 expression in isoform Alpha-independent manner (PubMed:26711253).</text>
</comment>
<comment type="function">
<molecule>Isoform Alpha-2</molecule>
<text>Has lower transcriptional activation activity than isoform Alpha. Exerts a dominant negative effect on isoform Alpha trans-repression mechanism (PubMed:20484466).</text>
</comment>
<comment type="function">
<molecule>Isoform GR-P</molecule>
<text evidence="27">Increases activity of isoform Alpha.</text>
</comment>
<comment type="function">
<molecule>Isoform Alpha-B</molecule>
<text evidence="29 46">More effective than isoform Alpha in transcriptional activation, but not repression activity.</text>
</comment>
<comment type="function">
<molecule>Isoform 10</molecule>
<text evidence="59">Has transcriptional activation activity.</text>
</comment>
<comment type="function">
<molecule>Isoform Alpha-C1</molecule>
<text evidence="46">Has transcriptional activation activity.</text>
</comment>
<comment type="function">
<molecule>Isoform Alpha-C2</molecule>
<text evidence="46">Has transcriptional activation activity.</text>
</comment>
<comment type="function">
<molecule>Isoform Alpha-C3</molecule>
<text evidence="46 66 69">Has highest transcriptional activation activity of all isoforms created by alternative initiation (PubMed:15866175, PubMed:23820903). Has transcriptional repression activity (PubMed:23303127). Mediates glucocorticoid-induced apoptosis (PubMed:23303127, PubMed:23820903).</text>
</comment>
<comment type="function">
<molecule>Isoform Alpha-D1</molecule>
<text evidence="46">Has transcriptional activation activity.</text>
</comment>
<comment type="function">
<molecule>Isoform Alpha-D2</molecule>
<text evidence="46">Has transcriptional activation activity.</text>
</comment>
<comment type="function">
<molecule>Isoform Alpha-D3</molecule>
<text evidence="46 66 69">Has lowest transcriptional activation activity of all isoforms created by alternative initiation (PubMed:15866175, PubMed:23820903). Has transcriptional repression activity (PubMed:23303127).</text>
</comment>
<comment type="subunit">
<text evidence="15 16 20 22 37 39 40 41 44 45 47 49 50 52 54 55 57 63 64 65 71 77 78 88 89 90">Heteromultimeric cytoplasmic complex with HSP90AA1, HSPA1A/HSPA1B, and FKBP5 or another immunophilin such as PPID, STIP1, or the immunophilin homolog PPP5C (PubMed:21730050). Upon ligand binding FKBP5 dissociates from the complex and FKBP4 takes its place, thereby linking the complex to dynein and mediating transport to the nucleus, where the complex dissociates (By similarity). Probably forms a complex composed of chaperones HSP90 and HSP70, co-chaperones CDC37, PPP5C, TSC1 and client protein TSC2, CDK4, AKT, RAF1 and NR3C1; this complex does not contain co-chaperones STIP1/HOP and PTGES3/p23 (PubMed:29127155). Directly interacts with UNC45A (PubMed:16478993). Binds to DNA as a homodimer, and as heterodimer with NR3C2 or the retinoid X receptor. Binds STAT5A and STAT5B homodimers and heterodimers (By similarity). Interacts with NRIP1, POU2F1, POU2F2 and TRIM28 (By similarity). Interacts with several coactivator complexes, including the SMARCA4 complex, CREBBP/EP300, TADA2L (Ada complex) and p160 coactivators such as NCOA2 and NCOA6 (PubMed:10866662, PubMed:12151000, PubMed:12686538, PubMed:9154805, PubMed:9590696). Interaction with BAG1 inhibits transactivation (PubMed:10477749). Interacts with HEXIM1, PELP1 and TGFB1I1 (PubMed:12415108, PubMed:15211577, PubMed:15941832). Interacts with NCOA1 (PubMed:9590696). Interacts with NCOA3, SMARCA4, SMARCC1, SMARCD1, and SMARCE1 (By similarity). Interacts with CLOCK, CRY1 and CRY2 in a ligand-dependent fashion (PubMed:19141540, PubMed:21980503, PubMed:22170608). Interacts with CIART (By similarity). Interacts with RWDD3 (By similarity). Interacts with UBE2I/UBC9 and this interaction is enhanced in the presence of RWDD3 (By similarity). Interacts with GRIP1 (PubMed:15769988, PubMed:17635946). Interacts with NR4A3 (via nuclear receptor DNA-binding domain), represses transcription activity of NR4A3 on the POMC promoter Nur response element (NurRE) (PubMed:15591535). Directly interacts with PNRC2 to attract and form a complex with UPF1 and DCP1A; the interaction leads to rapid mRNA degradation (PubMed:25775514). Interacts with GSK3B (PubMed:18838540). Interacts with FNIP1 and FNIP2 (PubMed:27353360). Interacts (via C-terminus) with HNRNPU (via C-terminus) (PubMed:9353307). Interacts with MCM3AP (PubMed:16914116). Interacts (via domain NR LBD) with HSP90AA1 and HSP90AB1 (By similarity). In the absence of hormonal ligand, interacts with TACC1 (PubMed:20078863).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-296087">
<id>P31749</id>
<label>AKT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-603614">
<id>Q03135</id>
<label>CAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-353826">
<id>P01730</id>
<label>CD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-1049011">
<id>P41235</id>
<label>HNF4A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-739493">
<id>Q6ZU52</id>
<label>KIAA0408</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-1348">
<id>P06239</id>
<label>LCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-949763">
<id>P82094</id>
<label>TMF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-5743705">
<id>P59598</id>
<label>Asxl1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-493507">
<id>P04150</id>
</interactant>
<interactant intactId="EBI-918333">
<id>Q62667</id>
<label>Mvp</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15750116">
<id>P04150-1</id>
</interactant>
<interactant intactId="EBI-688662">
<id>Q61026</id>
<label>Ncoa2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform Alpha</molecule>
<subcellularLocation>
<location evidence="45 52 54 76 86">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="45 52 54 76 86">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="61">Mitochondrion</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="72">Cytoplasm</location>
<location evidence="72">Cytoskeleton</location>
<location evidence="72">Spindle</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="72">Cytoplasm</location>
<location evidence="72">Cytoskeleton</location>
<location evidence="72">Microtubule organizing center</location>
<location evidence="72">Centrosome</location>
</subcellularLocation>
<text evidence="16 54 76 86">After ligand activation, translocates from the cytoplasm to the nucleus. In the presence of NR1D1 shows a time-dependent subcellular localization, localizing to the cytoplasm at ZT8 and to the nucleus at ZT20 (By similarity). Lacks this diurnal pattern of localization in the absence of NR1D1, localizing to both nucleus and the cytoplasm at ZT8 and ZT20 (By similarity).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform Beta</molecule>
<subcellularLocation>
<location evidence="56 75 86">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="56 75">Cytoplasm</location>
</subcellularLocation>
<text evidence="56 75">Expressed predominantly in the nucleus with some expression also detected in the cytoplasm.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform Alpha-B</molecule>
<subcellularLocation>
<location evidence="46">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="46">Cytoplasm</location>
</subcellularLocation>
<text evidence="46">After ligand activation, translocates from the cytoplasm to the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>P04150-1</id>
<name>Alpha</name>
<name>Alpha-A</name>
<name>GR-alphaA</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P04150-2</id>
<name>Beta</name>
<name>Beta-A</name>
<sequence type="described" ref="VSP_003703"/>
</isoform>
<isoform>
<id>P04150-3</id>
<name>Alpha-2</name>
<name>Gamma</name>
<sequence type="described" ref="VSP_007363"/>
</isoform>
<isoform>
<id>P04150-6</id>
<name>Beta-2</name>
<sequence type="described" ref="VSP_007363 VSP_003703"/>
</isoform>
<isoform>
<id>P04150-5</id>
<name>GR-A alpha</name>
<sequence type="described" ref="VSP_013340"/>
</isoform>
<isoform>
<id>P04150-7</id>
<name>GR-A beta</name>
<sequence type="described" ref="VSP_013340 VSP_003703"/>
</isoform>
<isoform>
<id>P04150-4</id>
<name>GR-P</name>
<sequence type="not described"/>
</isoform>
<isoform>
<id>P04150-8</id>
<name>Alpha-B</name>
<name>GR-alphaB</name>
<sequence type="described" ref="VSP_018773"/>
</isoform>
<isoform>
<id>P04150-9</id>
<name>Beta-B</name>
<sequence type="described" ref="VSP_018773 VSP_003703"/>
</isoform>
<isoform>
<id>P04150-10</id>
<name>10</name>
<name>hGRDelta313-338</name>
<sequence type="described" ref="VSP_043908"/>
</isoform>
<isoform>
<id>P04150-11</id>
<name>Alpha-C1</name>
<name>GR-alphaC1</name>
<sequence type="described" ref="VSP_058317"/>
</isoform>
<isoform>
<id>P04150-12</id>
<name>Alpha-C2</name>
<name>GR-alphaC2</name>
<sequence type="described" ref="VSP_058316"/>
</isoform>
<isoform>
<id>P04150-13</id>
<name>Alpha-C3</name>
<name>GR-alphaC3</name>
<sequence type="described" ref="VSP_058315"/>
</isoform>
<isoform>
<id>P04150-14</id>
<name>Alpha-D1</name>
<name>GR-alphaD1</name>
<sequence type="described" ref="VSP_058314"/>
</isoform>
<isoform>
<id>P04150-15</id>
<name>Alpha-D2</name>
<name>GR-alphaD2</name>
<sequence type="described" ref="VSP_058313"/>
</isoform>
<isoform>
<id>P04150-16</id>
<name>Alpha-D3</name>
<name>GR-alphaD3</name>
<sequence type="described" ref="VSP_058312"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="24 72 81 86">Widely expressed including bone, stomach, lung, liver, colon, breast, ovary, pancreas and kidney (PubMed:25847991). In the heart, detected in left and right atria, left and right ventricles, aorta, apex, intraventricular septum, and atrioventricular node as well as whole adult and fetal heart (PubMed:10902803). Isoform Beta: Widely expressed including brain, bone marrow, thymus, spleen, liver, kidney, pancreas, lung, fat, skeletal muscle, heart, placenta and blood leukocytes (PubMed:7769088, PubMed:8621628). Isoform Alpha-2: Expressed at low level.</text>
</comment>
<comment type="induction">
<text evidence="28">Isoform Alpha: Up-regulated by TNF (at protein level). Isoform Beta: Up-regulated by TNF and becomes the predominant isoform which may lead to glucocorticoid resistance (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="72 79">Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain (PubMed:3841189). The ligand-binding domain is required for correct chromosome segregation during mitosis although ligand binding is not required (PubMed:25847991).</text>
</comment>
<comment type="PTM">
<text evidence="55 64">Acetylation by CLOCK reduces its binding to glucocorticoid response elements and its transcriptional activity.</text>
</comment>
<comment type="PTM">
<text evidence="29 30">Increased proteasome-mediated degradation in response to glucocorticoids (PubMed:11555652). Isoform Alpha-B appears to be more susceptible to proteolytic degradation than isoform Alpha (PubMed:11435610).</text>
</comment>
<comment type="PTM">
<text evidence="16 34 53 54 72">Phosphorylated in the absence of hormone; becomes hyperphosphorylated in the presence of glucocorticoid. The Ser-203, Ser-226 and Ser-404-phosphorylated forms are mainly cytoplasmic, and the Ser-211-phosphorylated form is nuclear (PubMed:12000743, PubMed:18838540). Phosphorylation at Ser-211 increases transcriptional activity (PubMed:12000743, PubMed:18483179). Phosphorylation at Ser-203, Ser-226 and Ser-404 decreases signaling capacity (PubMed:12000743, PubMed:18483179, PubMed:18838540). Phosphorylation at Ser-404 may protect from glucocorticoid-induced apoptosis (PubMed:18838540). Phosphorylation at Ser-203 and Ser-211 is not required in regulation of chromosome segregation (PubMed:25847991). May be dephosphorylated by PPP5C, attenuates NR3C1 action (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="15 36">Sumoylation at Lys-277 and Lys-293 negatively regulates its transcriptional activity (PubMed:12144530). Sumoylation at Lys-703 positively regulates its transcriptional activity in the presence of RWDD3 (By similarity). Sumoylation at Lys-277 and Lys-293 is dispensable whereas sumoylation at Lys-703 is critical for the stimulatory effect of RWDD3 on its transcriptional activity (By similarity). Heat shock increases sumoylation in a RWDD3-dependent manner (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="16">Ubiquitinated; restricts glucocorticoid-mediated transcriptional signaling.</text>
</comment>
<comment type="polymorphism">
<text>Carriers of the 22-Glu-Lys-23 allele are relatively more resistant to the effects of GCs with respect to the sensitivity of the adrenal feedback mechanism than non-carriers, resulting in a better metabolic health profile. Carriers have a better survival than non-carriers, as well as lower serum CRP levels. The 22-Glu-Lys-23 polymorphism is associated with a sex-specific, beneficial body composition at young-adult age, as well as greater muscle strength in males.</text>
</comment>
<comment type="disease" evidence="31 32 35 45 51 52 58 60 67 70 73 74 76 80">
<disease id="DI-04226">
<name>Glucocorticoid resistance, generalized</name>
<acronym>GCCR</acronym>
<description>An autosomal dominant disease characterized by increased plasma cortisol concentration and high urinary free cortisol, resistance to adrenal suppression by dexamethasone, and the absence of Cushing syndrome typical signs. Clinical features include hypoglycemia, hypertension, metabolic alkalosis, chronic fatigue and profound anxiety.</description>
<dbReference type="MIM" id="615962"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Beta</molecule>
<text evidence="25">High constitutive expression by neutrophils may provide a mechanism by which these cells escape glucocorticoid-induced cell death and up-regulation by proinflammatory cytokines such as IL8 further enhances their survival in the presence of glucocorticoids during inflammation.</text>
</comment>
<comment type="miscellaneous">
<text evidence="21">Can up- or down-modulate aggregation and nuclear localization of expanded polyglutamine polypeptides derived from AR and HD through specific regulation of gene expression. Aggregation and nuclear localization of expanded polyglutamine proteins are regulated cellular processes that can be modulated by this receptor, a well-characterized transcriptional regulator.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha</molecule>
<text evidence="46">Predominant physiological form.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha-2</molecule>
<text evidence="95">Due to a partial intron retention.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Beta-2</molecule>
<text evidence="95">Due to a partial intron retention.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform GR-A alpha</molecule>
<text evidence="83">Lacks exons 5, 6 and 7. Found in glucocorticoid-resistant myeloma patients.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform GR-A beta</molecule>
<text evidence="83">Lacks exons 5, 6 and 7.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform GR-P</molecule>
<text evidence="83">Encoded by exons 2-7 plus several basepairs from the subsequent intron region. Lacks the ligand binding domain. Accounts for up to 10-20% of mRNAs.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha-B</molecule>
<text evidence="95">Produced by alternative initiation at Met-27 of isoform Alpha.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Beta-B</molecule>
<text evidence="46 95">Produced by alternative initiation at Met-27 of isoform Beta.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha-C1</molecule>
<text evidence="46">Produced by alternative initiation at Met-86 of isoform Alpha.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha-C2</molecule>
<text evidence="46">Produced by alternative initiation at Met-90 of isoform Alpha.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha-C3</molecule>
<text evidence="46">Produced by alternative initiation at Met-98 of isoform Alpha.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha-D1</molecule>
<text evidence="46">Produced by alternative initiation at Met-316 of isoform Alpha.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha-D2</molecule>
<text evidence="46">Produced by alternative initiation at Met-331 of isoform Alpha.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform Alpha-D3</molecule>
<text evidence="46">Produced by alternative initiation at Met-336 of isoform Alpha.</text>
</comment>
<comment type="similarity">
<text evidence="95">Belongs to the nuclear hormone receptor family. NR3 subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/nr3c1/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Glucocorticoid_receptor"/>
<text>Glucocorticoid receptor entry</text>
</comment>
<dbReference type="EMBL" id="X03225">
<property type="protein sequence ID" value="CAA26976.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X03348">
<property type="protein sequence ID" value="CAA27054.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AH005496">
<property type="protein sequence ID" value="AAB64353.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AH005496">
<property type="protein sequence ID" value="AAB64354.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205546">
<property type="protein sequence ID" value="ADP91135.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205547">
<property type="protein sequence ID" value="ADP91138.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205548">
<property type="protein sequence ID" value="ADP91141.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205549">
<property type="protein sequence ID" value="ADP91144.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205550">
<property type="protein sequence ID" value="ADP91147.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205551">
<property type="protein sequence ID" value="ADP91150.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205552">
<property type="protein sequence ID" value="ADP91153.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205553">
<property type="protein sequence ID" value="ADP91156.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205554">
<property type="protein sequence ID" value="ADP91159.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205555">
<property type="protein sequence ID" value="ADP91162.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205556">
<property type="protein sequence ID" value="ADP91165.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205557">
<property type="protein sequence ID" value="ADP91168.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205558">
<property type="protein sequence ID" value="ADP91171.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205559">
<property type="protein sequence ID" value="ADP91174.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205560">
<property type="protein sequence ID" value="ADP91177.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205561">
<property type="protein sequence ID" value="ADP91180.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205562">
<property type="protein sequence ID" value="ADP91183.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205563">
<property type="protein sequence ID" value="ADP91186.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205564">
<property type="protein sequence ID" value="ADP91189.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205565">
<property type="protein sequence ID" value="ADP91192.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205566">
<property type="protein sequence ID" value="ADP91195.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205567">
<property type="protein sequence ID" value="ADP91198.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205568">
<property type="protein sequence ID" value="ADP91201.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205569">
<property type="protein sequence ID" value="ADP91204.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205570">
<property type="protein sequence ID" value="ADP91207.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205571">
<property type="protein sequence ID" value="ADP91210.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205572">
<property type="protein sequence ID" value="ADP91213.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205573">
<property type="protein sequence ID" value="ADP91216.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205574">
<property type="protein sequence ID" value="ADP91219.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205575">
<property type="protein sequence ID" value="ADP91222.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205576">
<property type="protein sequence ID" value="ADP91225.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205577">
<property type="protein sequence ID" value="ADP91228.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205578">
<property type="protein sequence ID" value="ADP91231.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205579">
<property type="protein sequence ID" value="ADP91234.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205580">
<property type="protein sequence ID" value="ADP91237.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205581">
<property type="protein sequence ID" value="ADP91240.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205582">
<property type="protein sequence ID" value="ADP91243.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205583">
<property type="protein sequence ID" value="ADP91246.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205584">
<property type="protein sequence ID" value="ADP91249.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ205585">
<property type="protein sequence ID" value="ADP91252.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AM183262">
<property type="protein sequence ID" value="CAJ65924.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ450643">
<property type="protein sequence ID" value="AED99114.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U01351">
<property type="protein sequence ID" value="AAA16603.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223594">
<property type="protein sequence ID" value="BAD97314.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX640610">
<property type="protein sequence ID" value="CAE45716.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY436590">
<property type="protein sequence ID" value="AAQ97180.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU332858">
<property type="protein sequence ID" value="ABY87547.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005601">
<property type="protein sequence ID" value="AAC34207.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004782">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC091925">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW61872.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW61873.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015610">
<property type="protein sequence ID" value="AAH15610.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M69104">
<property type="protein sequence ID" value="AAA88049.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AH002750">
<property type="protein sequence ID" value="AAA53151.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S68378">
<property type="protein sequence ID" value="AAB20466.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34258.1">
<molecule id="P04150-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4278.1">
<molecule id="P04150-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47298.1">
<molecule id="P04150-2"/>
</dbReference>
<dbReference type="PIR" id="A93370">
<property type="entry name" value="QRHUGA"/>
</dbReference>
<dbReference type="PIR" id="B93370">
<property type="entry name" value="QRHUGB"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000167.1">
<molecule id="P04150-1"/>
<property type="nucleotide sequence ID" value="NM_000176.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001018084.1">
<molecule id="P04150-1"/>
<property type="nucleotide sequence ID" value="NM_001018074.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001018085.1">
<molecule id="P04150-1"/>
<property type="nucleotide sequence ID" value="NM_001018075.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001018086.1">
<molecule id="P04150-1"/>
<property type="nucleotide sequence ID" value="NM_001018076.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001018087.1">
<molecule id="P04150-1"/>
<property type="nucleotide sequence ID" value="NM_001018077.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001018661.1">
<molecule id="P04150-2"/>
<property type="nucleotide sequence ID" value="NM_001020825.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001019265.1">
<molecule id="P04150-3"/>
<property type="nucleotide sequence ID" value="NM_001024094.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191187.1">
<molecule id="P04150-8"/>
<property type="nucleotide sequence ID" value="NM_001204258.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191188.1">
<molecule id="P04150-11"/>
<property type="nucleotide sequence ID" value="NM_001204259.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191189.1">
<molecule id="P04150-12"/>
<property type="nucleotide sequence ID" value="NM_001204260.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191190.1">
<molecule id="P04150-13"/>
<property type="nucleotide sequence ID" value="NM_001204261.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191191.1">
<molecule id="P04150-14"/>
<property type="nucleotide sequence ID" value="NM_001204262.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191192.1">
<molecule id="P04150-15"/>
<property type="nucleotide sequence ID" value="NM_001204263.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001191193.1">
<molecule id="P04150-16"/>
<property type="nucleotide sequence ID" value="NM_001204264.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005268476.1">
<property type="nucleotide sequence ID" value="XM_005268419.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005268477.1">
<property type="nucleotide sequence ID" value="XM_005268420.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005268479.1">
<molecule id="P04150-3"/>
<property type="nucleotide sequence ID" value="XM_005268422.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005268480.1">
<molecule id="P04150-3"/>
<property type="nucleotide sequence ID" value="XM_005268423.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864886.1">
<property type="nucleotide sequence ID" value="XM_017009397.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864887.1">
<property type="nucleotide sequence ID" value="XM_017009398.1"/>
</dbReference>
<dbReference type="PDB" id="1M2Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/D=521-777"/>
</dbReference>
<dbReference type="PDB" id="1NHZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="1P93">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D=500-777"/>
</dbReference>
<dbReference type="PDB" id="3BQD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=525-777"/>
</dbReference>
<dbReference type="PDB" id="3CLD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.84"/>
<property type="chains" value="A/B=521-777"/>
</dbReference>
<dbReference type="PDB" id="3E7C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=521-777"/>
</dbReference>
<dbReference type="PDB" id="3H52">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D=528-777"/>
</dbReference>
<dbReference type="PDB" id="3K22">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=521-777"/>
</dbReference>
<dbReference type="PDB" id="3K23">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B/C=521-777"/>
</dbReference>
<dbReference type="PDB" id="4CSJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="4HN5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=417-506"/>
</dbReference>
<dbReference type="PDB" id="4HN6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B=417-506"/>
</dbReference>
<dbReference type="PDB" id="4LSJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=522-777"/>
</dbReference>
<dbReference type="PDB" id="4MDD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=522-777"/>
</dbReference>
<dbReference type="PDB" id="4P6W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=526-777"/>
</dbReference>
<dbReference type="PDB" id="4P6X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/C/E/G/I/K=523-777"/>
</dbReference>
<dbReference type="PDB" id="4UDC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="4UDD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="5CBX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/E/F=415-495"/>
</dbReference>
<dbReference type="PDB" id="5CBY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=415-495"/>
</dbReference>
<dbReference type="PDB" id="5CBZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/E/F=419-495"/>
</dbReference>
<dbReference type="PDB" id="5CC1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/W/X=417-506"/>
</dbReference>
<dbReference type="PDB" id="5E69">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=417-506"/>
</dbReference>
<dbReference type="PDB" id="5E6A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=417-506"/>
</dbReference>
<dbReference type="PDB" id="5E6B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=417-506"/>
</dbReference>
<dbReference type="PDB" id="5E6C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=417-506"/>
</dbReference>
<dbReference type="PDB" id="5E6D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=417-506"/>
</dbReference>
<dbReference type="PDB" id="5EMC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=411-500"/>
</dbReference>
<dbReference type="PDB" id="5EMP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=411-500"/>
</dbReference>
<dbReference type="PDB" id="5EMQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=411-500"/>
</dbReference>
<dbReference type="PDB" id="5G3J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="5G5W">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="5NFP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="5NFT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="5UC3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A/B=522-777"/>
</dbReference>
<dbReference type="PDB" id="5VA0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29"/>
<property type="chains" value="A/B=419-490"/>
</dbReference>
<dbReference type="PDB" id="5VA7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=419-488"/>
</dbReference>
<dbReference type="PDB" id="6BQU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=421-490"/>
</dbReference>
<dbReference type="PDB" id="6CFN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D/E/F/G/H=418-506"/>
</dbReference>
<dbReference type="PDB" id="6DXK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A/B=522-777"/>
</dbReference>
<dbReference type="PDB" id="6EL6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="6EL7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.18"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDB" id="6EL9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A=500-777"/>
</dbReference>
<dbReference type="PDBsum" id="1M2Z"/>
<dbReference type="PDBsum" id="1NHZ"/>
<dbReference type="PDBsum" id="1P93"/>
<dbReference type="PDBsum" id="3BQD"/>
<dbReference type="PDBsum" id="3CLD"/>
<dbReference type="PDBsum" id="3E7C"/>
<dbReference type="PDBsum" id="3H52"/>
<dbReference type="PDBsum" id="3K22"/>
<dbReference type="PDBsum" id="3K23"/>
<dbReference type="PDBsum" id="4CSJ"/>
<dbReference type="PDBsum" id="4HN5"/>
<dbReference type="PDBsum" id="4HN6"/>
<dbReference type="PDBsum" id="4LSJ"/>
<dbReference type="PDBsum" id="4MDD"/>
<dbReference type="PDBsum" id="4P6W"/>
<dbReference type="PDBsum" id="4P6X"/>
<dbReference type="PDBsum" id="4UDC"/>
<dbReference type="PDBsum" id="4UDD"/>
<dbReference type="PDBsum" id="5CBX"/>
<dbReference type="PDBsum" id="5CBY"/>
<dbReference type="PDBsum" id="5CBZ"/>
<dbReference type="PDBsum" id="5CC1"/>
<dbReference type="PDBsum" id="5E69"/>
<dbReference type="PDBsum" id="5E6A"/>
<dbReference type="PDBsum" id="5E6B"/>
<dbReference type="PDBsum" id="5E6C"/>
<dbReference type="PDBsum" id="5E6D"/>
<dbReference type="PDBsum" id="5EMC"/>
<dbReference type="PDBsum" id="5EMP"/>
<dbReference type="PDBsum" id="5EMQ"/>
<dbReference type="PDBsum" id="5G3J"/>
<dbReference type="PDBsum" id="5G5W"/>
<dbReference type="PDBsum" id="5NFP"/>
<dbReference type="PDBsum" id="5NFT"/>
<dbReference type="PDBsum" id="5UC3"/>
<dbReference type="PDBsum" id="5VA0"/>
<dbReference type="PDBsum" id="5VA7"/>
<dbReference type="PDBsum" id="6BQU"/>
<dbReference type="PDBsum" id="6CFN"/>
<dbReference type="PDBsum" id="6DXK"/>
<dbReference type="PDBsum" id="6EL6"/>
<dbReference type="PDBsum" id="6EL7"/>
<dbReference type="PDBsum" id="6EL9"/>
<dbReference type="SMR" id="P04150"/>
<dbReference type="BioGRID" id="109165">
<property type="interactions" value="809"/>
</dbReference>
<dbReference type="CORUM" id="P04150"/>
<dbReference type="DIP" id="DIP-576N"/>
<dbReference type="ELM" id="P04150"/>
<dbReference type="IntAct" id="P04150">
<property type="interactions" value="78"/>
</dbReference>
<dbReference type="MINT" id="P04150"/>
<dbReference type="STRING" id="9606.ENSP00000231509"/>
<dbReference type="BindingDB" id="P04150"/>
<dbReference type="ChEMBL" id="CHEMBL2034"/>
<dbReference type="DrugBank" id="DB00240">
<property type="generic name" value="Alclometasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04630">
<property type="generic name" value="Aldosterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00288">
<property type="generic name" value="Amcinonide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00394">
<property type="generic name" value="Beclomethasone dipropionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00443">
<property type="generic name" value="Betamethasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01222">
<property type="generic name" value="Budesonide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01410">
<property type="generic name" value="Ciclesonide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01013">
<property type="generic name" value="Clobetasol propionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13158">
<property type="generic name" value="Clobetasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00838">
<property type="generic name" value="Clocortolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01380">
<property type="generic name" value="Cortisone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13003">
<property type="generic name" value="Cortivazol"/>
</dbReference>
<dbReference type="DrugBank" id="DB11921">
<property type="generic name" value="Deflazacort"/>
</dbReference>
<dbReference type="DrugBank" id="DB01260">
<property type="generic name" value="Desonide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00547">
<property type="generic name" value="Desoximetasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01234">
<property type="generic name" value="Dexamethasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00223">
<property type="generic name" value="Diflorasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09095">
<property type="generic name" value="Difluocortolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB06781">
<property type="generic name" value="Difluprednate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01395">
<property type="generic name" value="Drospirenone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00687">
<property type="generic name" value="Fludrocortisone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00663">
<property type="generic name" value="Flumethasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00180">
<property type="generic name" value="Flunisolide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00591">
<property type="generic name" value="Fluocinolone acetonide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01047">
<property type="generic name" value="Fluocinonide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00324">
<property type="generic name" value="Fluorometholone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01185">
<property type="generic name" value="Fluoxymesterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00846">
<property type="generic name" value="Flurandrenolide"/>
</dbReference>
<dbReference type="DrugBank" id="DB13867">
<property type="generic name" value="Fluticasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB08906">
<property type="generic name" value="Fluticasone furoate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00588">
<property type="generic name" value="Fluticasone propionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB11619">
<property type="generic name" value="Gestrinone"/>
</dbReference>
<dbReference type="DrugBank" id="DB02210">
<property type="generic name" value="Hexane-1,6-Diol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00769">
<property type="generic name" value="Hydrocortamate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00741">
<property type="generic name" value="Hydrocortisone"/>
</dbReference>
<dbReference type="DrugBank" id="DB14538">
<property type="generic name" value="Hydrocortisone aceponate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14539">
<property type="generic name" value="Hydrocortisone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14540">
<property type="generic name" value="Hydrocortisone butyrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14541">
<property type="generic name" value="Hydrocortisone cypionate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14542">
<property type="generic name" value="Hydrocortisone phosphate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14543">
<property type="generic name" value="Hydrocortisone probutate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14544">
<property type="generic name" value="Hydrocortisone valerate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00367">
<property type="generic name" value="Levonorgestrel"/>
</dbReference>
<dbReference type="DrugBank" id="DB14596">
<property type="generic name" value="Loteprednol etabonate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00253">
<property type="generic name" value="Medrysone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00351">
<property type="generic name" value="Megestrol acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00959">
<property type="generic name" value="Methylprednisolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00834">
<property type="generic name" value="Mifepristone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00764">
<property type="generic name" value="Mometasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB14512">
<property type="generic name" value="Mometasone furoate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00717">
<property type="generic name" value="Norethisterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB12637">
<property type="generic name" value="Onapristone"/>
</dbReference>
<dbReference type="DrugBank" id="DB05423">
<property type="generic name" value="ORG-34517"/>
</dbReference>
<dbReference type="DrugBank" id="DB01384">
<property type="generic name" value="Paramethasone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01130">
<property type="generic name" value="Prednicarbate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00860">
<property type="generic name" value="Prednisolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB15566">
<property type="generic name" value="Prednisolone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00635">
<property type="generic name" value="Prednisone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00396">
<property type="generic name" value="Progesterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00896">
<property type="generic name" value="Rimexolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB14583">
<property type="generic name" value="Segesterone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00421">
<property type="generic name" value="Spironolactone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09091">
<property type="generic name" value="Tixocortol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00620">
<property type="generic name" value="Triamcinolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB08867">
<property type="generic name" value="Ulipristal"/>
</dbReference>
<dbReference type="DrugBank" id="DB00596">
<property type="generic name" value="Ulobetasol"/>
</dbReference>
<dbReference type="DrugCentral" id="P04150"/>
<dbReference type="GuidetoPHARMACOLOGY" id="625"/>
<dbReference type="iPTMnet" id="P04150"/>
<dbReference type="PhosphoSitePlus" id="P04150"/>
<dbReference type="BioMuta" id="NR3C1"/>
<dbReference type="DMDM" id="121069"/>
<dbReference type="EPD" id="P04150"/>
<dbReference type="jPOST" id="P04150"/>
<dbReference type="MassIVE" id="P04150"/>
<dbReference type="PaxDb" id="P04150"/>
<dbReference type="PeptideAtlas" id="P04150"/>
<dbReference type="PRIDE" id="P04150"/>
<dbReference type="ProteomicsDB" id="51657">
<molecule id="P04150-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51658">
<molecule id="P04150-10"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51659">
<molecule id="P04150-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51660">
<molecule id="P04150-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51661">
<molecule id="P04150-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51662">
<molecule id="P04150-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51663">
<molecule id="P04150-7"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51664">
<molecule id="P04150-8"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51665">
<molecule id="P04150-9"/>
</dbReference>
<dbReference type="Antibodypedia" id="1329">
<property type="antibodies" value="1220 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2908"/>
<dbReference type="Ensembl" id="ENST00000231509">
<molecule id="P04150-3"/>
<property type="protein sequence ID" value="ENSP00000231509"/>
<property type="gene ID" value="ENSG00000113580"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000343796">
<molecule id="P04150-1"/>
<property type="protein sequence ID" value="ENSP00000343205"/>
<property type="gene ID" value="ENSG00000113580"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394464">
<molecule id="P04150-1"/>
<property type="protein sequence ID" value="ENSP00000377977"/>
<property type="gene ID" value="ENSG00000113580"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394466">
<molecule id="P04150-3"/>
<property type="protein sequence ID" value="ENSP00000377979"/>
<property type="gene ID" value="ENSG00000113580"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000415690">
<molecule id="P04150-2"/>
<property type="protein sequence ID" value="ENSP00000387672"/>
<property type="gene ID" value="ENSG00000113580"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000424646">
<molecule id="P04150-10"/>
<property type="protein sequence ID" value="ENSP00000405282"/>
<property type="gene ID" value="ENSG00000113580"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000503201">
<molecule id="P04150-1"/>
<property type="protein sequence ID" value="ENSP00000427672"/>
<property type="gene ID" value="ENSG00000113580"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000504572">
<molecule id="P04150-3"/>
<property type="protein sequence ID" value="ENSP00000422518"/>
<property type="gene ID" value="ENSG00000113580"/>
</dbReference>
<dbReference type="GeneID" id="2908"/>
<dbReference type="KEGG" id="hsa:2908"/>
<dbReference type="UCSC" id="uc003lmy.4">
<molecule id="P04150-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2908"/>
<dbReference type="DisGeNET" id="2908"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000113580.14"/>
<dbReference type="GeneCards" id="NR3C1"/>
<dbReference type="HGNC" id="HGNC:7978">
<property type="gene designation" value="NR3C1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000113580">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="NR3C1"/>
<dbReference type="MIM" id="138040">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615962">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04150"/>
<dbReference type="OpenTargets" id="ENSG00000113580"/>
<dbReference type="Orphanet" id="786">
<property type="disease" value="Generalized glucocorticoid resistance syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA181"/>
<dbReference type="eggNOG" id="KOG3575">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XRZC">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156385"/>
<dbReference type="HOGENOM" id="CLU_020317_0_0_1"/>
<dbReference type="InParanoid" id="P04150"/>
<dbReference type="KO" id="K05771"/>
<dbReference type="OMA" id="LSFCFQT"/>
<dbReference type="PhylomeDB" id="P04150"/>
<dbReference type="TreeFam" id="TF106510"/>
<dbReference type="Reactome" id="R-HSA-3371497">
<property type="pathway name" value="HSP90 chaperone cycle for steroid hormone receptors (SHR)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-383280">
<property type="pathway name" value="Nuclear Receptor transcription pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4090294">
<property type="pathway name" value="SUMOylation of intracellular receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849473">
<property type="pathway name" value="PTK6 Expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8939902">
<property type="pathway name" value="Regulation of RUNX2 expression and activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9615017">
<property type="pathway name" value="FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"/>
</dbReference>
<dbReference type="SignaLink" id="P04150"/>
<dbReference type="SIGNOR" id="P04150"/>
<dbReference type="BioGRID-ORCS" id="2908">
<property type="hits" value="4 hits in 809 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NR3C1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04150"/>
<dbReference type="GeneWiki" id="Glucocorticoid_receptor"/>
<dbReference type="GenomeRNAi" id="2908"/>
<dbReference type="Pharos" id="P04150">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P04150"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P04150">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000113580">
<property type="expression patterns" value="Expressed in endothelial cell and 248 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P04150">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04150">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0042025">
<property type="term" value="C:host cell nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005815">
<property type="term" value="C:microtubule organizing center"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005759">
<property type="term" value="C:mitochondrial matrix"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005819">
<property type="term" value="C:spindle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0001047">
<property type="term" value="F:core promoter binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0004883">
<property type="term" value="F:glucocorticoid receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0051879">
<property type="term" value="F:Hsp90 protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004879">
<property type="term" value="F:nuclear receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005496">
<property type="term" value="F:steroid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990239">
<property type="term" value="F:steroid hormone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071549">
<property type="term" value="P:cellular response to dexamethasone stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071385">
<property type="term" value="P:cellular response to glucocorticoid stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071383">
<property type="term" value="P:cellular response to steroid hormone stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071560">
<property type="term" value="P:cellular response to transforming growth factor beta stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006325">
<property type="term" value="P:chromatin organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007059">
<property type="term" value="P:chromosome segregation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902895">
<property type="term" value="P:positive regulation of pri-miRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="DisProt" id="DP00030"/>
<dbReference type="Gene3D" id="1.10.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.50.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00014"/>
<dbReference type="InterPro" id="IPR001409">
<property type="entry name" value="Glcrtcd_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR035500">
<property type="entry name" value="NHR-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000536">
<property type="entry name" value="Nucl_hrmn_rcpt_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001723">
<property type="entry name" value="Nuclear_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001628">
<property type="entry name" value="Znf_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR013088">
<property type="entry name" value="Znf_NHR/GATA"/>
</dbReference>
<dbReference type="Pfam" id="PF02155">
<property type="entry name" value="GCR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00104">
<property type="entry name" value="Hormone_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00105">
<property type="entry name" value="zf-C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00528">
<property type="entry name" value="GLCORTICOIDR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00398">
<property type="entry name" value="STRDHORMONER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00047">
<property type="entry name" value="STROIDFINGER"/>
</dbReference>
<dbReference type="SMART" id="SM00430">
<property type="entry name" value="HOLI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00399">
<property type="entry name" value="ZnF_C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48508">
<property type="entry name" value="SSF48508"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51843">
<property type="entry name" value="NR_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00031">
<property type="entry name" value="NUCLEAR_REC_DBD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51030">
<property type="entry name" value="NUCLEAR_REC_DBD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0159">Chromosome partition</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0657">Pseudohermaphroditism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0754">Steroid-binding</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Glucocorticoid receptor" id="PRO_0000019937">
<location>
<begin position="1"/>
<end position="777"/>
</location>
</feature>
<feature type="domain" description="NR LBD" evidence="18">
<location>
<begin position="524"/>
<end position="758"/>
</location>
</feature>
<feature type="DNA-binding region" description="Nuclear receptor" evidence="17">
<location>
<begin position="418"/>
<end position="493"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="17">
<location>
<begin position="421"/>
<end position="441"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="17">
<location>
<begin position="457"/>
<end position="476"/>
</location>
</feature>
<feature type="region of interest" description="Modulating">
<location>
<begin position="1"/>
<end position="420"/>
</location>
</feature>
<feature type="region of interest" description="Required for high transcriptional activity of isoform Alpha-C3" evidence="69">
<location>
<begin position="98"/>
<end position="115"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CLOCK">
<location>
<begin position="485"/>
<end position="777"/>
</location>
</feature>
<feature type="region of interest" description="Hinge">
<location>
<begin position="487"/>
<end position="523"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CRY1" evidence="65">
<location>
<begin position="532"/>
<end position="697"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu/Pro/Ser/Thr-rich (PEST region)">
<location>
<begin position="399"/>
<end position="418"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="8"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="16">
<location>
<position position="23"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="45"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="113"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="134"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="141"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 34 53 72">
<location>
<position position="203"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="34 53 72">
<location>
<position position="211"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 53">
<location>
<position position="226"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 11">
<location>
<position position="267"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by GSK3-beta" evidence="54">
<location>
<position position="404"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="55">
<location>
<position position="480"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="55">
<location>
<position position="492"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="55">
<location>
<position position="494"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="55">
<location>
<position position="495"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="14">
<location>
<position position="258"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="36">
<location>
<position position="277"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="14">
<location>
<position position="277"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="36">
<location>
<position position="293"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="13">
<location>
<position position="293"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="16">
<location>
<position position="419"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="36">
<location>
<position position="703"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-D3." id="VSP_058312" evidence="46">
<location>
<begin position="1"/>
<end position="335"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-D2." id="VSP_058313" evidence="46">
<location>
<begin position="1"/>
<end position="330"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-D1." id="VSP_058314" evidence="46">
<location>
<begin position="1"/>
<end position="315"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-C3." id="VSP_058315" evidence="46">
<location>
<begin position="1"/>
<end position="97"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-C2." id="VSP_058316" evidence="46">
<location>
<begin position="1"/>
<end position="89"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-C1." id="VSP_058317" evidence="46">
<location>
<begin position="1"/>
<end position="85"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-B and isoform Beta-B." id="VSP_018773" evidence="95">
<location>
<begin position="1"/>
<end position="26"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 10." id="VSP_043908" evidence="92">
<location>
<begin position="313"/>
<end position="338"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Alpha-2 and isoform Beta-2." id="VSP_007363" evidence="94">
<original>G</original>
<variation>GR</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="splice variant" description="In isoform GR-A alpha and isoform GR-A beta." id="VSP_013340" evidence="95">
<location>
<begin position="491"/>
<end position="674"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Beta, isoform Beta-B, isoform Beta-2 and isoform GR-A beta." id="VSP_003703" evidence="93">
<original>VVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</original>
<variation>NVMWLKPESTSHTLI</variation>
<location>
<begin position="728"/>
<end position="777"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; reduces transactivation activity; does not affect transrepression activity; dbSNP:rs6190." id="VAR_014140" evidence="19 23 38 42 43 48 87 91">
<original>R</original>
<variation>K</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs148102613." id="VAR_015628" evidence="23">
<original>F</original>
<variation>L</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6192." id="VAR_014622" evidence="19 91">
<original>F</original>
<variation>V</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; associated in cis with A-321 and S-766 in one individual; doubles transactivation potential." id="VAR_075797" evidence="62">
<original>N</original>
<variation>D</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs542110718." id="VAR_015629" evidence="23">
<original>L</original>
<variation>F</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1241576112." id="VAR_015630" evidence="23">
<original>D</original>
<variation>N</variation>
<location>
<position position="233"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; associated in cis with D-72 and S-766 in one individual; doubles transactivation potential." id="VAR_075798" evidence="62">
<original>V</original>
<variation>A</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence variant" description="Enhances transactivation activity; does not affect transrepression activity; may increase sensitivity to exogenously administered glucocorticoids; may contribute to central obesity in men and show lack of association with other risk factors for coronary heart disease and diabetes mellitus; dbSNP:rs56149945." id="VAR_004675" evidence="19 23 26 48 85 87">
<original>N</original>
<variation>S</variation>
<location>
<position position="363"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_015631" evidence="84">
<original>C</original>
<variation>Y</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; unknown pathological significance; reduces transactivation activity; delays nuclear translocation; does not exert a dominant negative effect; impairs DNA binding." id="VAR_075799" evidence="67">
<original>V</original>
<variation>A</variation>
<location>
<position position="423"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; dbSNP:rs104893913." id="VAR_013472" evidence="31">
<original>R</original>
<variation>H</variation>
<location>
<position position="477"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; loss of DNA-binding and of transactivation activity; incomplete dexamethasone-induced translocation to the nucleus; no effect on dexamethasone-binding affinity compared with wild-type." id="VAR_077143" evidence="76">
<original>R</original>
<variation>S</variation>
<location>
<position position="477"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; decreased DNA-binding and transactivation activity; incomplete dexamethasone-induced translocation to the nucleus; no effect on dexamethasone-binding affinity compared with wild-type." id="VAR_077144" evidence="76">
<original>Y</original>
<variation>C</variation>
<location>
<position position="478"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; reduces transactivation activity; enhances transrepression activity; reduces affinity for ligand; delays nuclear translocation; does not exert a dominant negative effect; does not impair DNA binding." id="VAR_075800" evidence="60 74">
<original>T</original>
<variation>I</variation>
<location>
<position position="556"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; interferes with translocation to the nucleus and thereby strongly reduces transcription activation; is equally impaired in nuclear export; acts as dominant negative mutant; dbSNP:rs104893909." id="VAR_015632" evidence="32">
<original>I</original>
<variation>N</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In pseudohermaphroditism; female with hypokalemia due to glucocorticoid resistance; 6-fold reduction in binding affinity compared with the wild-type receptor; dbSNP:rs104893911." id="VAR_025014" evidence="33">
<original>V</original>
<variation>A</variation>
<location>
<position position="571"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; unknown pathological significance; reduces transactivation activity; enhances transrepression activity; reduces affinity for ligand; delays nuclear translocation; does not exert a dominant negative effect; does not impair DNA binding." id="VAR_075801" evidence="70">
<original>V</original>
<variation>G</variation>
<location>
<position position="575"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; dbSNP:rs104893908." id="VAR_004676" evidence="51">
<original>D</original>
<variation>V</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; loss of dexamethasone-binding, dexamethasone-induced translocation to the nucleus and of transactivation activity." id="VAR_077145" evidence="76">
<original>L</original>
<variation>P</variation>
<location>
<position position="672"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; has 50% binding affinity; dbSNP:rs104893914." id="VAR_013473" evidence="31">
<original>G</original>
<variation>S</variation>
<location>
<position position="679"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; unknown pathological significance; reduces transactivation; reduces affinity for ligand; exerts a dominant negative effect; does not impair DNA binding." id="VAR_075802" evidence="58">
<original>R</original>
<variation>Q</variation>
<location>
<position position="714"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; unknown pathological significance; reduces transactivation and transrepression activity; reduces affinity for ligand; delays nuclear translocation; does not impair DNA binding." id="VAR_075803" evidence="73">
<original>H</original>
<variation>R</variation>
<location>
<position position="726"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; dbSNP:rs1027058734." id="VAR_004677" evidence="80">
<original>V</original>
<variation>I</variation>
<location>
<position position="729"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; reduces transactivation of the glucocorticoid-inducible tumor virus promoter; reduces affinity for ligand; delays its nuclear translocation; acts as dominant negative mutant; dbSNP:rs121909727." id="VAR_071935" evidence="52">
<original>F</original>
<variation>L</variation>
<location>
<position position="737"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; alters interaction with NCOA2 and strongly reduces transcription activation; acts as dominant negative mutant; dbSNP:rs104893910." id="VAR_015633" evidence="35">
<original>I</original>
<variation>M</variation>
<location>
<position position="747"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs121909726." id="VAR_004678" evidence="82 84">
<original>L</original>
<variation>F</variation>
<location>
<position position="753"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; associated in cis with D-72 and A-321 in one individual; doubles transactivation potential." id="VAR_075804" evidence="62">
<original>N</original>
<variation>S</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="sequence variant" description="In GCCR; reduces transactivation of the glucocorticoid-inducible tumor virus promoter; reduces affinity for ligand; delays its nuclear translocation; acts as dominant negative mutant; dbSNP:rs104893912." id="VAR_071936" evidence="45">
<original>L</original>
<variation>P</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes expression of A-type isoforms." evidence="29 46">
<original>M</original>
<variation>T</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes expression of B-type isoforms." evidence="29 46">
<original>M</original>
<variation>T</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes expression of C-type isoforms; when associated with I-90 and I-98." evidence="46">
<original>M</original>
<variation>I</variation>
<location>
<position position="86"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes expression of C-type isoforms; when associated with I-86 and I-98." evidence="46">
<original>M</original>
<variation>I</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes expression of C-type isoforms; when associated with I-86 and I-90." evidence="46">
<original>M</original>
<variation>I</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transcription activation activity of isoform Alpha-C3 by half." evidence="69">
<original>D</original>
<variation>A</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transcription activation activity of isoform Alpha-C3 by half. Suppresses apoptosis-inducing activity of isoform Alpha-C3. Impairs recruitment of selected coregulators onto DNA binding sites." evidence="69">
<original>D</original>
<variation>K</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces activity of isoform Alpha-C3 by half." evidence="69">
<original>QQ</original>
<variation>LL</variation>
<location>
<begin position="106"/>
<end position="107"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect the activity of isoform Alpha-C3." evidence="69">
<original>SS</original>
<variation>AA</variation>
<location>
<begin position="113"/>
<end position="114"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transactivation by the ADA complex." evidence="88">
<original>F</original>
<variation>D</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transactivation by the ADA complex." evidence="88">
<original>I</original>
<variation>D</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces transactivation by the ADA complex; when associated with V-224 and F-225." evidence="88">
<original>L</original>
<variation>A</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces transactivation by the ADA complex." evidence="88">
<original>L</original>
<variation>E</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces expression of target genes IGFBP1 and IRF8." evidence="53">
<original>S</original>
<variation>A</variation>
<location>
<position position="211"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces transactivation by the ADA complex." evidence="88">
<original>W</original>
<variation>A</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces transactivation by the ADA complex; when associated with A-194 and F-225." evidence="88">
<original>L</original>
<variation>V</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces transactivation by the ADA complex; when associated with A-194 and V-224." evidence="88">
<original>L</original>
<variation>F</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation and enhances transcriptional activation." evidence="53">
<original>S</original>
<variation>A</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces transactivation by the ADA complex; when associated with V-236." evidence="88">
<original>F</original>
<variation>L</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces transactivation by the ADA complex; when associated with L-235." evidence="88">
<original>L</original>
<variation>V</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces sumoylation. Almost complete loss of sumoylation; when associated with R-293." evidence="36">
<original>K</original>
<variation>R</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces sumoylation. Almost complete loss of sumoylation; when associated with R-277." evidence="36">
<original>K</original>
<variation>R</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes expression of D-type isoforms; when associated with I-331 and I-336." evidence="46">
<original>M</original>
<variation>I</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes expression of D-type isoforms; when associated with I-316 and I-336." evidence="46">
<original>M</original>
<variation>I</variation>
<location>
<position position="331"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes expression of D-type isoforms; when associated with I-316 and I-331." evidence="46">
<original>M</original>
<variation>I</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation. Does not affect translocation to the nucleus following ligand stimulation. Increases protein half-life and transcriptional repressor activity. Alters repertoire of regulated genes. Increases cell death." evidence="54">
<original>S</original>
<variation>A</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect translocation to the nucleus following ligand stimulation." evidence="54">
<original>S</original>
<variation>D</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in acetylation and in repression of its transcriptional activity by CLOCK-ARNTL/BMAL1 heterodimer. Complete loss in acetylation and in repression of its transcriptional activity by CLOCK-ARNTL/BMAL1 heterodimer; when associated with A-492; A-494 and A-495." evidence="55">
<original>K</original>
<variation>A</variation>
<location>
<position position="480"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in acetylation and in repression of its transcriptional activity by CLOCK-ARNTL/BMAL1 heterodimer. Complete loss in acetylation and in repression of its transcriptional activity by CLOCK-ARNTL/BMAL1 heterodimer; when associated with A-480; A-494 and A-495." evidence="55">
<original>K</original>
<variation>A</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in acetylation and in repression of its transcriptional activity by CLOCK-ARNTL/BMAL1 heterodimer; when associated with A-495. Complete loss in acetylation and in repression of its transcriptional activity by CLOCK-ARNTL/BMAL1 heterodimer; when associated with A-480; A-492 and A-495." evidence="55">
<original>K</original>
<variation>A</variation>
<location>
<position position="494"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in acetylation and in repression of its transcriptional activity by CLOCK-ARNTL/BMAL1 heterodimer; when associated with A-494. Complete loss in acetylation and in repression of its transcriptional activity by CLOCK-ARNTL/BMAL1 heterodimer; when associated with A-480; A-492 and A-494." evidence="55">
<original>K</original>
<variation>A</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces activation mediated by ligand binding domain; when associated with A-590." evidence="37">
<original>R</original>
<variation>A</variation>
<location>
<position position="585"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces activation mediated by ligand binding domain; when associated with A-585." evidence="37">
<original>D</original>
<variation>A</variation>
<location>
<position position="590"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases solubility. No effect on transactivation by dexamethasone." evidence="37">
<original>F</original>
<variation>S</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases transactivation by dexamethasone by 95%." evidence="37">
<original>P</original>
<variation>A</variation>
<location>
<position position="625"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases dimerization and transactivation by dexamethasone; when associated with S-602." evidence="37">
<original>I</original>
<variation>A</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduces sumoylation. Inhibits the stimulatory effect of RWDD3 on its transcriptional activity." evidence="36 68">
<original>K</original>
<variation>R</variation>
<location>
<position position="703"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAD97314." ref="7" evidence="95">
<original>R</original>
<variation>G</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAD97314." ref="7" evidence="95">
<original>A</original>
<variation>T</variation>
<location>
<position position="754"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="422"/>
<end position="424"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="430"/>
<end position="432"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="435"/>
<end position="437"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="439"/>
<end position="450"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="458"/>
<end position="461"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="467"/>
<end position="472"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="474"/>
<end position="484"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="488"/>
<end position="497"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="525"/>
<end position="527"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="532"/>
<end position="538"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="550"/>
<end position="552"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="556"/>
<end position="579"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="584"/>
<end position="586"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="589"/>
<end position="615"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="617"/>
<end position="619"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="621"/>
<end position="624"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="627"/>
<end position="629"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="631"/>
<end position="634"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="639"/>
<end position="655"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="660"/>
<end position="671"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="673"/>
<end position="675"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="683"/>
<end position="702"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="704"/>
<end position="706"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="708"/>
<end position="741"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="743"/>
<end position="745"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="751"/>
<end position="765"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="766"/>
<end position="768"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="769"/>
<end position="771"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="10">
<location sequence="P04150-8">
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="10">
<location sequence="P04150-9">
<position position="1"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1M2Z"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3K22"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4P6W"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UDD"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E69"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UC3"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6CFN"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6DXK"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P06536"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P06537"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00407"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01189"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391209"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10477749"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10639135"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10866662"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10898924"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10902803"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11238589"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11344238"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11358809"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11381138"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11435610"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11555652"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11589680"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11701741"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11932321"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12000743"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12050230"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12144530"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12151000"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12351458"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12415108"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12686538"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15211577"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15276593"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15292341"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15591535"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15769988"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15866175"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15941832"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16030164"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16478993"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16914116"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1704018"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17635946"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18483179"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18838540"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19141540"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19248771"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20078863"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20335448"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20484466"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21362280"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21664385"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21701417"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21730050"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21980503"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22170608"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23303127"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23426617"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23508108"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23820903"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24483153"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25775514"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25847991"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26031419"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26541474"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26711253"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27120390"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27353360"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29127155"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3841189"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7683692"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7769088"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8316249"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8358712"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8358735"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8445027"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8621628"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9150737"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9154805"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9353307"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9590696"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="92" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17404046"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2867473"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="95" type="ECO:0000305"/>
<sequence length="777" mass="85659" checksum="C5C90C9A5DD16AAB" modified="1986-11-01" version="1">MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAVASQSDSKQRRLLVDFPKGSVSNAQQPDLSKAVSLSMGLYMGETETKVMGNDLGFPQQGQISLSSGETDLKLLEESIANLNRSTSVPENPKSSASTAVSAAPTEKEFPKTHSDVSSEQQHLKGQTGTNGGNVKLYTTDQSTFDILQDLEFSSGSPGKETNESPWRSDLLIDENCLLSPLAGEDDSFLLEGNSNEDCKPLILPDTKPKIKDNGDLVLSSPSNVTLPQVKTEKEDFIELCTPGVIKQEKLGTVYCQASFPGANIIGNKMSAISVHGVSTSGGQMYHYDMNTASLSQQQDQKPIFNVIPPIPVGSENWNRCQGSGDDNLTSLGTLNFPGRTVFSNGYSSPSMRPDVSSPPSSSSTATTGPPPKLCLVCSDEASGCHYGVLTCGSCKVFFKRAVEGQHNYLCAGRNDCIIDKIRRKNCPACRYRKCLQAGMNLEARKTKKKIKGIQQATTGVSQETSENPGNKTIVPATLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMFLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>